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1 Introduction 
 
In all ages of history, since antiquity [53] until 
today, we find that a very significant amount of 
anatomical, physiological, clinical and surgical 
studies had been dedicated to hydrocephalus. 
Likewise, we see that the history of 
neurosurgery had developed through the 
advances relating to the understanding and 
treatment of this pathology [110]. Maybe this is 
due to the fact that probably hydrocephalus is 
in general the most complete neurosurgical 
pathology, because apart of its etiological 
mechanism; its solution is essentially invasive 
or surgical. The 20th century brought 
technological advances that allowed us to 
explain pathophysiological mechanisms and 
established new diagnoses. In this sense, we 
encounter idiopathic normal pressure 
hydrocephalus (iNPH), which since its first 
  2 
description in 1964 [1], [52], until the present, 
as we will see later, proposes a great number 
of questions. The etiology and the 
pathophysiological mechanism that explains it 
is still uncertain, which represents without a 
doubt a challenge for modern neuroscience. 
Fortunately, the continuous search for 
explanations has allowed to introduce in its 
study new diagnostic strategies, which have 
thrown light into the matter permitting the 
suggestion of new theories. This constitutes 
the reason for this dissertation. Due to the fact 
that these new diagnostic techniques and 
theoretical proposals are not definitive, some 
specialized centers in neurosurgery with 
research capabilities have directed resources 
to further study this disease. This is the case 
of the Neurosurgery Department of the 
Tübingen University Hospital (Germany), 
where under the guidance of Prof. Dr. med. 
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Martin Schuhmann exists a line of research 
about hydrocephalus and in particular about 
iNPH. The possibility to use the medical facility 
and the required technology, to have access to 
the patients, and the support of Professor 
Martin Schuhmann made of this work an 
enriching personal and professional 
experience. 
 
This dissertation has two parts: The first part is 
a detailed bibliographical review about 
hydrocephalus and the most modern 
approaches to its understanding. This part has 
been written to offer to the reader the 
opportunity to learn about the most unknown 
disease treated by Neurosurgeons. It has to be 
considered as a separate effort outside of the 
usual thesis framework, which was created out 
of the enthusiasm of the author while trying to 
understand the phenomenon.  
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The theoretical first part begins with the 
general, pathophysiological aspects, diagnosis 
and treatment of iNPH. After that, the basic 
concepts, the classifications and demographic 
data will be presented. Then there will be an 
emphasis on pathophysiology, an attempt to 
establish differences easily recognizable 
among the current theories that try to explain 
it, a systematic comparison of them will be 
presented. In addition to the latter, it will be 
explained in detail the new proposal 
represented by the hydrodynamic theory [42]. 
As a contribution of this dissertation, this 
theory will be described and presented through 
diagrams. This part will end with the 
explanation of the current proposals for the 
diagnosis and treatment of iNPH.  
 
The second part represents that investigative 
scientific part of the dissertation. Apart from a 
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clinical description of the patient cohort, the 
intracranial pressure (ICP) monitoring and 
cerebrospinal fluid (CSF) dynamics monitoring 
are the foundation of this work. It will be 
attempted to establish a relation between the 
pathophysiological proposal of the 
hydrodynamic theory and the results of ICP 
monitoring in order to predict the clinical 
improvement of our patients after draining the 
CSF with a shunt implantation. In short, and 
apart from the statistical results, this 
dissertation tries to be a theoretical and 
practical contribution in relation to the study 
and treatment of iNPH. 
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2 Part I - Review of Pathophysiology and 
Diagnosis/Treatment of iNPH 
 
2.1 Cerebrospinal fluid (CSF)  
The CSF is a clear and colorless fluid [101], 
which has mechanical protection, nutritive 
functions, transporting oxygen and glucose, 
immunological functions, transporting 
antibodies and immunoglobulin, and carrier 
functions, transporting and eliminating 
substances formed in the nervous system, like 
neurotransmitters, toxic or waste substances. 
Furthermore, recent studies indicate that CSF 
is not only an ultrafiltration of blood plasma, 
but that its production comes from energy 
dependent processes such as active transport 
[2]. Regarding its production, 80% of CSF is 
produced in the choroid plexus, while the 
remaining 20% is produced by the ependymal 
cells of the ventricles, the pial cerebral surface 
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and comes from the interstitial intracerebral 
space [112]. The total volume of ventricular 
and subarachnoid CSF ranges from 130 to 
150 ml. The production rate is estimated to 
0,30 - 0,40 ml per minute, which means up to 
24 ml per hour or 500 ml per day [87]. The 
CSF pressure when measured by a lumbar 
puncture in lateral decubital position ranges 
from 60 to 150 mm of H2O (8-10 mmHg), the 
CSF intracranial pressure of a standing up 
person is close to zero or negative up to -10 
mmHg [79]. 
 
Bulk flow theory 
The classical theory that tries to explain the 
production, circulation and reabsorption of 
CSF, was proposed by Dandy. It has received 
since then many contributions [26] and thus it 
is today the most accepted theory, known as 
CSF bulk flow theory [22]. It sustains that at 
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the ventricular level the pressure is higher and 
then it decreases progressively along the 
subarachnoid space. For this reason and due 
to arterial pulsations of the choroid plexus, the 
CSF, which is produced in the latter, flows in 
caudal direction from its formation place 
(primarily the lateral ventricles) through the 
intraventricular foramina to the third ventricle 
[101]. Then it continues through the cerebral 
aqueduct to the fourth ventricle, from which it 
reaches through the fourth ventricle foramina 
(medial and lateral) the peribulbar and 
perispinal subarachnoid spaces. From these 
spaces it flows in rostral direction and through 
the tentorial notch reaches the basal and 
ambient cisterns, from which it ascends to the 
lateral and superior surfaces of both cerebral 
hemispheres. It is hypothesized that the 
arachnoid villi is the greatest absorption site. 
These villi gather to form the arachnoid 
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granulations, which calcify and grow in number 
and size with age. The CSF continues caudally 
through the central foramen of the spinal cord 
and along its subarachnoid space as well. 
According to this theory, the CSF absorption 
process in the venous sinuses happens when 
its pressure is greater than that of the sinuses. 
This could be expressed in a similar way to 
Ohm’s Law (V=IR), where V (or voltage) would 
represent the difference between the 
pressures of CSF and the venous system, and 
it is this difference which causes the CSF to go 
into the veins; I (or current) expresses the 
velocity of the CSF flow, which in physiological 
conditions is equal to the velocity of its 
production; and R (resistance) represents the 
resistance to the CSF passing into the venous 
system, this resistance increases in cases 
where the CSF circulation is blocked, which in 
turn brings an increase of intracranial pressure 
  10 
[112]. This theory was supported in the 1960s 
by studies that reported that those 
granulations could act as mechanic valves 
[116]. Additional support came from other 
investigations that made cisternographies with 
radionucleotides, in which 24 hours after 
applying radioisotopes to the CSF, it could be 
seen that the site of maximal accumulation of 
these radioisotopes was precisely the 
granulations [26]. However, recent studies that 
used radioactively marked albumin, reported 
that 90% of this protein was absorbed at the 
spinal canal, being maximally concentrated at 
the convexity of the sacrolumbar area 24 
hours after the application. Therefore the CSF 
reabsorption mechanism proposed by the bulk 
flow theory would be incorrect [41], [43]. The 
belief that these villi act as unidirectional flow 
valves that absorb or transport CSF has been 
questioned as well, since there is no 
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anatomical or experimental evidence of this 
claim. Studies using electronic microscopy 
showed that each villus has a continuous fine 
membrane through which CSF flows, having a 
lineal increase rate, which depends on the 
CSF pressure (over 68 mmH2O), but there 
was no valve system. Other studies using the 
same technology indicate that fine tubules 
covered with endothelium allow the CSF to 
flow indirectly toward the venous sinuses and 
when the venous pressure increases 
exceeding the CSF pressure, then 
compression at the level of the villi occurs that 
shut those tubules, which prevents blood 
extravasation from the veins to the 
subarachnoid space [101]. 
 
Modern theory of CSF 
Recently has appeared a theory that tries to 
explain the CSF physiology called modern 
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CSF physiology and brain water [42]. It 
proposes that the CSF is produced and 
absorbed in any part of the central nervous 
system (CNS), where the former happens 
primarily at a production web in the choroid 
plexus and the latter at a minute web of 
capillary absorption in the subarachnoid space 
of the whole CNS. Additionally it establishes 
that the capillaries also produce an important 
quantity of interstitial fluid, which is 
approximately two times that of the CSF. 
Then, in case there is a fluid obstruction at 
intraventricular level, this fluid would substitute 
the CSF in the subarachnoid space. On the 
brain’s external surface, there is between the 
interstitial fluid and the CSF a fast and random 
process of mixing and diffusion, which 
happens because of the cerebral arterial 
pulse. The transport of said mixture takes 
place because of the difference in its material 
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concentration gradient, for this reason it can 
happen in all directions. At intraventricular 
level, despite existing arterial pulsations, the 
dominant bulk flow is unidirectional, which 
goes from the ventricles to the subarachnoid 
space. This theory calls the mixture between 
CSF and interstitial fluid “brain water”, which is 
characterized by a low protein concentration 
(0,4% of the protein concentration in plasma) 
and a great chemical similarity between both 
fluids that makes difficult their separation. 
Because of the latter, the fluid of the interstitial 
space is defined as interstitial fluid and the 
external fluid of the brain as CSF. The 
filtration, absorption and homeostasis of brain 
water is maintained by a fluid exchange 
through the cerebral and arachnoid capillary 
membrane, which is governed by the Starling 
principle. This principle asserts that at each 
side of the capillary wall there are two 
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counteracting forces that maintain the balance 
regarding the fluid exchange. These two forces 
are the hydrostatic pressure, which is related 
to fluid filtration, and the oncotic or colloid 
osmotic pressure, which is related with fluid 
absorption. Due to the properties of the 
arteriole and the cerebral capillary, there is a 
fluid homeostatic balance that helps to 
maintain a physiological and positive 
intracranial pressure. The close relationship 
between production and absorption of both 
CSF and interstitial fluid occurs at the cerebral 
capillaries, in a similar way as it happens in all 
the other capillaries of the body, i. e., through 
the active absorption of proteins and other 
macromolecules from the plasma to the CSF. 
 
2.2 Hydrocephalus 
Hydrocephalus is recognized as a pathological 
entity since the fifth century B. C. Its name 
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comes from the greek words ὕδωρ (water) 
and κεφαλη (head), which would mean 
water inside the head, although it is not 
referring to water but to cerebrospinal fluid 
(CSF) [110]. It is traditionally defined as the 
excessive accumulation of CSF in the 
ventricular system, which brings as a 
consequence its abnormal dilation. Due to 
direct brain monitoring and to gradient 
pressure analysis using MRI and CT appeared 
a new concept of hydrocephalus [44], [45], 
which asserts that because of the brain tissue 
plasticity, the brain responds to local forces 
(for example, pressure changes) with 
displacement, deformation and by being 
remodeled. This remodeling of the brain 
parenchyma and the CSF space is what is 
defined as hydrocephalus [25]. The ventricles 
enlargement at the expense of restricting the 
subarachnoid space indicates that there is an 
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increased regional force from the ventricles 
toward the subarachnoid space. The pressure 
gradient that appears is called transmantle 
pulsatile stress or transmantle pressure. This 
stress is a dynamic phenomenon that acts 
through time, depends on the pulse waves, 
and is the only possible force that could be 
responsible for the brain tissue and the CSF 
space deformation [47]. It also asserts that this 
stress can be reversed or reduced through 
CSF shunting and that the subsequent 
normalization of the spaces involved indicates 
that the transmantle pulsatile stress really 
exists. 
 
Classification 
Hydrocephalus is classically classified in two 
big groups, obstructive and non obstructive 
Hydrocephalus. Non obstructive 
Hydrocephalus may theoretically be caused by 
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an increased CSF production or due to an 
atrophy process of the brain parenchyma, 
where a passive enlargement of the ventricles 
occurs. This last kind is also called 
Hydrocephalus ex vacuo, but it should be 
noted that strictly speaking from a 
pathophysiological point of view, this is not a 
real hydrocephalus. Obstructive 
Hydrocephalus is subclassified in 
communicating and non communicating. 
Communicating hydrocephalus is present 
when the CSF flow is free inside and out of the 
ventricular system but is diminished or 
obstructed everywhere beyond the ventricular 
outlets, classically believed to be obstructed at 
the reabsorption level, i. e. at the level of the 
arachnoid villi or granulations, along the 
superior sagittal sinus [38]. Non 
communicating cases are those where we find 
obstruction evidence of the fluid flow inside or 
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at the outlet of the ventricular system. The 
hydrodynamic concept also classifies the 
disease in two groups: acute and chronic 
hydrocephalus [42]. We speak of acute 
hydrocephalus when there is a new obstructive 
process of the intraventricular flow or outflow. 
Chronic hydrocephalus is subdivided in two 
kinds: communicating hydrocephalus and 
chronic obstructive hydrocephalus. Restricted 
arterial pulsation and increased pulse pressure 
of the brain capillaries maintain the ventricles 
enlargement in the two kinds of chronic 
hydrocephalus. This understanding proposes 
as main cause of chronic hydrocephalus a 
decreased intracranial compliance and not 
CSF malabsorption. 
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2.3 Idiopathic normal pressure hydrocephalus 
(iNPH) or idiopathic adult hydrocephalus 
syndrome (IAHS) 
The classic view defines it as a communicating 
hydrocephalus [49], which presents normal 
CSF pressure levels. It is characterized by 
being chronic and presenting the symptomatic 
triad that includes gait disorders, dementia and 
urinary incontinence, which can be reversible 
under treatment. Continuous monitoring of 
intracranial pressure (ICP) in these patients 
has allowed to demonstrate that those 
„normal“ pressure levels could present 
aleatory elevations. Because of this, the better 
name should be “idiopathic adult 
hydrocephalus syndrome”, however the 
denomination “idiopathic normal pressure 
hydrocephalus” continues to be used because 
of its historical tradition. 
  20 
The hydrodynamic point of view proposes a 
new definition of iNPH. According to this 
theory, this kind of hydrocephalus is chronic 
and communicating, in which there is a 
deformation of the brain and the CSF space. 
The ventriculomegaly is present with a normal 
or almost normal intracranial pressure. All of 
this is related to a decreased intracranial 
compliance, which causes an increased 
intracranial pulsatility which effects 
ventriculomegaly.  
 
Etiology 
Etiologically it could be idiopathic (65%) or 
secondary (35%) [57], the latter being 
associated to states after subarachnoid 
hemorrhage, cranioencephalic trauma, 
neoplasia, postsurgical states, congenital 
malformations, and inflammatory diseases of 
the brain or the meninges, meningeal 
  21 
carcinomatosis being included [94]. The 
precise triggering or etiological factor has not 
been elucidated. Age related deep white 
matter lesions have been described as a 
possible etiological explanation of iNPH [65]. 
There is a second hit theory [12], which states 
that iNPH could begin in infancy as an external 
hydrocephalus that would be followed in old 
age by different grades of deep white matter 
ischemia. This would produce a decrease in 
the traction force of the ventricles. However, 
according to this theory, the deep white matter 
ischemia is a cause of iNPH but not the only 
one [14]. Other studies show that in some 
cases the ventriculomegaly exists 20 years 
before the patient develops the symptomatic 
triad of iNPH [13]. Another pathological entity 
that supports the chronic and progressive 
aspects of hydrocephalus, which begins in 
childhood and becomes symptomatic in 
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adulthood, one of its signs being adult 
macrocephaly, is the so called LOVA (long-
standing overt ventriculomegaly of the adult) 
[83], [84]. 
The hydrodynamic theory suggests that 
communicating hydrocephalus has a direct 
relation with the vascular disease, which would 
bring a decreased arterial compliance and an 
increased capillary pulse pressure [42]. This 
vascular disease is in turn associated to 
multiple factors such as old age, arterial 
hypertension, brain arteriosclerosis, diabetic 
microangiopathy, and arterial ectasia among 
others. Nevertheless, there remain still many 
doubts about the predisposing and/or 
unleashing factor, since not every patient with 
vascular comorbidity develops iNPH in old 
age. However it is true that most patients, who 
are diagnosed with the disease, have one or 
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some of these vascular factors in their 
personal history. 
 
Epidemiology 
Regarding its epidemiology, there are no world 
statistics. However, a multicentral and 
prospective study carried out in Japan with a 
sample of 117 patients, whose average age 
was between 74 years old (+/- 5) and 58% 
were male [47]. Another study carried out in 
Norway encompassing 220 000 persons, 
reported a prevalence of 21,9 and an 
incidence of 5,5 in every 100 000 persons, 
both of which increased with age. Besides it 
suggested that those results should be 
considered as minimal estimates and that its 
presence is not associated neither to race nor 
gender [15]. Other studies in small populations 
indicate that despite being underdiagnosed, 
because there is no consultation when its 
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symptoms are present, the disease appears in 
more than 0,40% of the general population 
older than 65 [16] and represents between 1 to 
6% of all dementias [109]. 
 
Pathophysiology: Classic theory 
Pathophysiologically its true mechanism 
remains unclear and because of this there is a 
constant debate, with different theories being 
proposed trying to explain it. The fact that this 
CSF reabsorption decrease and its 
subsequent accumulation in the ventricular 
system do not generate chronic intracranial 
hypertension [3], [44], but chronic and 
progressive ventriculomegaly, was explained 
by Hakim by applying the law of Pascal 
regarding fluids contained in an elastic 
compartment. According to the hydraulic press 
effect [38], [42], [49], the intracranial pressure 
(ICP) is a phenomenon that depends on 
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various physiological factors: first, the 
arteriole-capillary blood pressure, which 
through vasoconstriction changes manages to 
modify the ICP and the CSF pressure; second, 
the venous pressure, which regulates the 
intracranial blood volume; third, the brain 
parenchyma, which is comparable to a sponge 
made of viscoelastic material [78], whose cells 
are full of fluid (extracellular fluid and brain 
blood included) and its progressive 
deformation is attributed to the collapse of 
parenchymal veins; and fourth, some 
pathological element, which is not always 
present. He also stated that in order to 
evaluate the intracranial pressure changes, it 
has to be taken into account that in 
physiological conditions there is a balance 
between CSF, brain volume, vascular volume 
and the strength of the arteriole-capillary 
vessels. In the case of iNPH, he proposed that 
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the existence of a partial block regarding CSF 
circulation would produce hydrocephalus. 
According to this theory there are two phases 
in the disease. In the first one, there is a 
transitory period of intracranial hypertension, 
which comes as a result after a pressure 
gradient between the ventricular system and 
the subarachnoid space is established. Thus, 
using the equation (Force = Pressure x 
Surface), it explains the appearance of 
ventriculomegaly. This pressure increase 
persists until the formation and absorption of 
CSF reach a balance. Presumably this is due 
to the fact that brain arteriolo-capillary 
pressure, intracranial blood volume and CSF 
pressure equilibrate each other in this 
pathological condition. In the second phase 
the ventriculomegaly persists, therefore the 
intracranial pressure decreases due to the fact 
that a smaller CSF pressure is being exerted 
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on a bigger contact surface. Despite a 
normalization of CSF pressure, the 
ventriculomegaly remains, and therefore the 
clinical symptomatology remains as well. 
When there is a new increase of CSF 
pressure, the ventriculomegaly increased 
again until reaching a new equilibrium point 
[20], [93]. 
 
Definition of terms 
Before going on and with a didactical end in 
mind, it is necessary to define the following 
neuro-hemodynamic concepts, which are 
essential in order to understand the 
hydrodynamic theory, which will be presented 
immediately afterward. 
Pulse Pressure: is defined as the difference 
between systolic arterial pressure (SAP) and 
diastolic arterial pressure (DAP). It is 
expressed in mmHg and is considered an 
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indicator of arterial distensibility. There are 
studies that demonstrate that the pulse 
pressure increases with age, both in men and 
women, simultaneously with SAP increase, 
mainly in the population older than 60 [5]. 
 
Perfusion pressure (PP) and cerebral 
perfusion pressure (CPP): the perfusion 
pressure of any tissue is equal to the 
difference between mean arterial pressure 
(MAP) and the venous pressure (VP); PP = 
PAM ˗ VP. Because the venous pressure is 
similar or slightly lower than the ICP, and that 
at intracranial level the dynamics of vascular 
flow is closely related to it, the CPP is defined 
as the difference between mean arterial 
pressure and intracranial pressure; CPP = 
MAP – ICP [112]. The greatest threshold value 
which is accepted for adults ranges between 
60-70 mmHg [21]. 
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Vessel distensibility: it is defined as the 
vessel’s capability to distend because of 
pressure changes, accompanied by a 
decreased resistance to the fluid flow through 
them. It is expressed in the following way: 
distensibility = volume increase / pressure 
increase x original volume. The distensibility is 
inversely proportional to vessel Elastance [51]. 
 
Elastance: generically it is define as a 
measure of the tendency that a structure with 
elastic properties has to return to its original 
form once the deforming force has been 
removed. In medical physiology it usually 
refers to the measure of the tendency of a 
hollow viscus (e.g. urinary bladder or blood 
vessel) to return to its original shape once the 
force that distends or compresses it 
disappears [103]. 
  30 
Intracranial compliance (C): also called space 
adaptability or volumetric distensibility, is the 
brain capability to adapt to changes in volume 
(Vd) inside the cranium in order to compensate 
intracranial pressure changes (Pd) [75]. In 
analytical terms, it is defined as the relation 
between the received intracranial volume 
difference and the intracranial pressure 
difference that said volume exerts: C = Vd / Pd 
[28]. Regarding the intracranial dynamics, it 
must be said that the compliance is inversely 
proportional to pulse velocity. While the 
transmission of pulse pressure in a non 
adaptable cavity takes place at the speed of 
sound, the transmission velocity of intracranial 
pulse pressure is much more slower. This is 
due to the fact that both intracranial veins and 
spinal thecal sac have a high space 
adaptability or compliance [42]. 
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Vessel capacitance: also called vessel 
adaptability or vessel compliance is defined as 
the total amount of blood which can be stored 
in the blood vessels from a specific part of the 
circulation for every mercury millimeter of 
pressure. This means that the greater the 
vessel adaptability or capacitance is, the 
easier it will be that the vessel distends 
because of a pressure increase. Capacitance 
= vessel volume increase / vessel pressure 
increase [51]. 
 
Vessel impedance (Z): it is the hindrance that 
the arterial tree system of ramifications 
(hydraulic) presents to both the establishment 
of blood flow and its pressures. Said in another 
way, it is the opposition to the circulation of 
pulsatile flow. Impedance describes through its 
components the state of circulatory ways and 
the coupling of fluid and pressure between 
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these ways and organs. This includes viscosity 
effects, ramifications and angulations, changes 
in diameter, and arterial elasticity 
(distensibility). Therefore it helps to evaluate 
the physiology of the circulatory system. In 
analytical terms, it can be expressed as the 
magnitude (Z) that establishes a relation or 
quotient between tension (V) and current 
intensity (I): Z = V / I [88]. 
 
Monro-Kellie Doctrine [59], [81], [114]: it 
asserts that the cranial cavity is a semi-closed 
and rigid space, which contains a constant 
volume in each moment of the cardiac cycle. 
The total intracranial volume (Vc) is composed 
by the combination of the following four 
elements: first, the brain parenchyma 
(+capillary blood) (Vcerebral), which represents 
approximately 80% of intracranial content; 
second, the CSF (VCSF), which represents 
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nearly 10%; third and fourth, arterial (Varterial 
blood) and venous blood (Vvenous blood) 
respectively, both of which represent the 
remaining 10% of intracranial content. These 
four elements are encircled by the dura mater, 
which is of low elasticity and is in turn covered 
by a rigid container, i.e., the cranium. 
Analytically it is expressed in the following 
way: Vc= Vcerebral + Varterial blood +Vvenous blood+ 
VCSF. Given the case that one of this 
components increases in volume, the others 
will be affected and therefore have to adapt. 
This they accomplish by structural alteration in 
order to compensate for the lack of space, 
which forces them to diminish their volume 
inside the cranium (displacement). The 
compensatory displacement of the affected 
components is only temporal, but if the 
alteration continues they will be functionally 
affected. In addition to this, there would be an 
  34 
intracranial pressure increase, due to the fact 
that fluids are incompressible. Recently, some 
authors have indicated that the Monro-Kelly 
hypothesis lets out of consideration the 
material properties of the brain. According to 
this mathematical model of hydrocephalus 
[78], the severity and chronicity of 
physiological and neurological changes could 
be determined by these properties. 
 
Windkessel effect: it is the arterial tree system 
capability to transform the pulsatile flow of the 
central arteries in a continuous flow during the 
diastole, which is required by the peripheral 
tissues. As we well know, the great arteries 
have two main functions, which despite being 
different are closely related and regulated 
between each other/them. The first one is 
called conduction function, which is related to 
the arterial pressure static component (mean 
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arterial pressure). They accomplish this 
function, because they constitute low 
resistance ducts of blood distribution, which 
allow them to deliver an adequate blood 
supply to the peripheral organs. The second 
one is called damping function, which is 
related to the pulsatile component (pulse 
pressure), i.e., they damp the pressure 
oscillations caused by the intermittent nature 
of the ventricular ejection [71], [82], [86]. Due 
to this damping function, the great arteries 
store a part of the systolic volume during the 
systolic ejection (in normal conditions nearly 
60%), which is returned during the diastole, 
losing 15% of stored energy as heat or 
dissipated energy. The latter is denominated 
Windkessel arterial effect. 
 
Stroke volume (SV) [96]: it is the volume of 
blood pumped from a heart ventricle with each 
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beat. It can be expressed as the substraction 
of the end-systolic volume (ESV) from the end-
diastolic volume (EDV). SV = EDV ˗ ESV. 
 
CSF stroke volume: it is defined as the CSF 
mean volume that flows through an encephalic 
cavity during both the systole and diastole [97]. 
If the cavity is the ventricle, it is called 
ventricular CSF stroke volume and if it is the 
aqueduct, then it is called aqueductal CSF 
stroke volume. 
 
Pathophysiology: Hydrodynamic theory 
Continuing with the pathophysiology, there is 
another explanation, which tries to make clear 
the pathophysiological origin of iNPH. It is put 
forward by the so called “hydrodynamic theory” 
[42], which was developed by Greitz on the 
basis of MRI observations and measurements 
of arterial, venous and CSF pulsatility [44]. 
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According to Greitz et al. [46], there are 
volumetric changes in physiological conditions, 
in which the features of cerebral expansion 
could be inferred through the Monro-Kellie 
doctrine modified by Weed [114]. They say 
that total expansion has two components, i.e. 
arterial and brain expansion, which are difficult 
to differentiate. On one hand, the intracranial 
arteries expansion during the systole is 
compensated by the proportional CSF outflow 
through the foramen magnum and venous 
blood outflow to the dural venous sinuses. On 
the other, the brain expansion takes place 
when the intracranial pressure is lower than 
the CSF spinal pressure and when there is a 
simultaneous increase of total CSF intracranial 
volume. This is possible due to arterial 
expansion, which is responsible for the main 
part of the cervical CSF systole, because it 
creates space after its conclusion. The brain 
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expansion comes from an increase in brain 
volume, which during the late systole 
compresses the ventricular system and mainly 
the veins. Strangely, while the blood is still 
inside the arteries, the CSF plunges through 
the foramen magnum into the cranial cavity. 
The anatomo-functional explanation of this 
comes from the fact that said arterial systolic 
expansion compresses the venous outlets of 
the bridging vein, causing a systolic flow at the 
venous sinuses. Functionally, it could be said 
that the dural venous sinuses are located 
outside the cranial cavity, which causes 
compression at the venous outlet. Because of 
the latter the fall of pressure in this location is 
maximal. At the same time there is a 
recirculating CSF flow, which is caused by 
intracranial extracerebral arterial pulsations. 
According to the Law of Pascal, the increased 
CSF pressure caused by the pulse wave 
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entering into the cranium is distributed across 
the entire intracranial space, which equilibrates 
the pressure difference. Despite of this, there 
appear new temporal pressure gradients 
during each cardiac cycle; therefore the flow 
effects produce intracranial fluid displacement 
[42]. 
This theory proposes that iNPH or 
communicating hydrocephalus is characterized 
by a disorder of the intracranial pulsations 
complex harmony, i.e. between the brain 
arterial pulse and the CSF pulsatility, due to a 
decreased intracranial compliance. According 
to this reasoning, a chronic reduction of 
intracranial compliance restricts arterial 
expansion, which unleashes a series of effects 
on intracranial vascular and CSF dynamics, 
which in turn cause normal pressure 
ventriculomegaly, and also perpetuate and 
produce ulterior compliance decreases. In this 
  40 
way a vicious circle is formed. In relation to 
this theory, it is pertinent to recall that in recent 
animal experiments with kaolin injection in the 
basal cisterns, it was observed a decreased 
intracranial compliance of the basal arteries 
and a direct interference with CSF pulsatile 
motion at that level, which increased the CSF 
pulsatility and produced ventriculomegaly [70], 
[113]. 
The main effects caused by decreased 
intracranial compliance are the following: 
decreased intracranial stroke volume, 
increased CSF pulse pressure, decreased 
brain blood flow, and lastly decreased 
intracranial arterial expansion. In turn, this 
diminished arterial expansibility has the 
following consequences: first, increased 
vascular impedance; second, breakdown of 
the Windkessel effect along the main vessels; 
and third, increased arterial pulse wave. As it 
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will be explained later, all these effects have 
as final consequence ventricular enlargement 
and diminished blood brain flow. 
In order to make this work an explanatory tool 
of this pathophysiological mechanism, the 
effects just mentioned will be treated in detail. 
As it will be explained in what follows, these 
effects are closely related between them, 
having all of them the same starting point, and 
having intermediate and final mechanisms in 
common as well. Because of this, there are 
pathological positive feedback processes that 
form a vicious circle, which would explain the 
chronic and progressive aspects of iNPH. 
Additionally, we can see that through 
diagnostic methods it is possible to confirm the 
occurrence of these pathological effects. 
Decreased intracranial compliance causes: a 
decreased intracranial stroke volume, an 
increase of CSF pulse pressure, a diminished 
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expansion of intracranial arteries, and a 
diminished brain blood flow. In patients with 
communicating hydrocephalus, the intracranial 
stroke volume is diminished in approximately 
50%. This is known because of studies made 
with flow-sensitive MRI [56], which 
demonstrated that in these patients the stroke 
volume at the craniocervical-junction is 
diminished in nearly 50% and it is also 
diminished in a third at the intracranial venous 
sinuses. The diminished intracranial ejection 
volume produces, on the one hand, a 
diminished brain blood flow, which in turn 
diminishes the transcapillary pressure 
difference between blood and tissue, 
conducing to a diminished fluid exchange 
through the capillary wall. In this way the CSF 
absorption at the capillary level is affected. On 
the other hand, the diminished intracranial 
compliance directly increases the CSF pulse 
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pressure (approximately 6 times) [30]. These 
two main effects, i. e. diminished intracranial 
ejection volume and increased CSF pulse 
pressure, directly diminishes in one order of 
magnitude the intracranial compliance, which 
is the proportion or relation between volume 
change and pressure change [42]. In this way 
the first positive feedback circle is formed, 
which helps to perpetuate the mechanism that 
diminishes the intracranial compliance. 
Additionally the combination of these two 
effects brings forth an increased transmission 
pressure from the CSF to the vascular system, 
which also has a direct diminishing effect on 
the CSF absorption at the brain capillary. The 
diminished CSF absorption, which is the 
consequence of a flow and pressure disorder, 
can be seen through a lumbar infusion test 
with intracranial pressure monitoring, in which 
we observe an increased resistance of the 
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CSF outflow (Rcsf) [115]. The diminished 
intracranial compliance causes in turn a 
diminishing of the intracranial arteries 
expansion, which will unleash a series of more 
complex mechanisms that will be explained 
later on. One of them is an increased 
intracranial vascular impedance. This 
increases the resistance to the pulsatile flow 
which results in a diminished blood flow 
average and also a diminished flow of the 
whole brain blood. As it was already 
mentioned, the decrease in blood brain flow 
diminishes the CSF absorption at the brain 
capillary [42]. (See diagram 1). 
The intracranial compliance decrease causes 
a diminished arterial expansion, which 
produces, on the one hand, the breakdown of 
the Windkessel mechanism along the great 
vessels at the base of the cranium, and on the 
other, the arterial pulse wave increase. The 
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Windkessel mechanism breakdown decreases 
the arterial diastolic flow, which in turn 
increases the pulsatility of intracranial arteries. 
The latter can be seen through the transcranial 
Doppler, where the pulsatility index would 
appear increased, i. e., bigger than one. The 
arterial pulsatility increase disrupts the 
synchrony between the arterial, venous and 
CSF pulses, resulting in an increase of the 
parenchyma capillaries pulsation [44]. This 
increase raises the brain pressure in 
comparison to the subarachnoid space, which 
brings about a decrease of the pressure 
difference between the vascular system and 
brain tissue. The latter allows the transmission 
of the systolic pressure from the capillary to 
the brain tissue. The wave increase of the 
intracranial arterial pulse happens due to the 
fact that the arteries cannot expand and 
because of this the buffer effect decreases, 
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which is responsible for softening the arterial 
pulse wave. 
 
The decrease of arterial expansion decreases 
the CSF volume conduction, which bypasses 
the brain capillary, i.e., the one which directly 
goes from the (expanding) artery to the 
(compressed) bridge veins. The energy, that is 
generated here, creates a forced pressure and 
transmission volume of the pulse wave from 
the artery to the capillary and brain tissue. 
Subsequently the brain capillary absorbs this 
hydraulic energy of the pulse wave, resulting in 
an increase of the brain capillary pulsations. 
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Diagram 1 
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Later on the brain capillary absorbs this 
hydraulic energy of the pulse wave, which 
results in a brain capillary pulsations increase. 
In physiological conditions, that energy is 
absorbed by the artery and not the capillary. In 
the end, this also leads to the transmission of 
the systolic pressure from the capillary to the 
brain tissue. As it was already explained, the 
latter is also a consequence of an increased 
intracranial arterial pulsatility, which in turn is a 
consequence of the breakdown of the 
Windkessel mechanism and a decreased 
arterial diastolic flow. Additionally, this 
increase of the intracranial arterial pulsatility 
contributes to an increase of the arterial pulse 
wave, so that it reinforces the increase of the 
capillary pulsatility of the brain parenchyma. 
As it was already said, both the pulsatility 
increase of the brain capillaries and the pulse 
wave increase at the artery are responsible for 
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the transmission of the systolic pressure from 
the capillary toward the brain tissue. This 
systolic pressure transmission causes a 
compression increase of the vessels along 
their course inside the subarachnoid space, 
which produces a compression of the vessel 
capacitance and an increase of venous brain 
pressure. The reduction of vessel capacitance 
directly decreases the brain compliance and 
additionally increases vascular resistance, 
which is followed by a decrease of the brain 
blood flow. The increase of vascular resistance 
can be shown as a small increase of the CSF 
mean pressure, which is not meaningful in 
relation to intracranial pressure in general, 
given the fact that the CSF total pressure is 
normal or almost normal in communicating 
hydrocephalus. The increase of brain venous 
pressure is followed by a decrease of 
perfusion pressure and consequently by the 
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decrease of brain blood flow [104]. On the 
other hand, a decreased compliance joined by 
a decreased brain blood flow disrupts the 
normal autoregulation mechanisms by which 
the blood vessels regulate the flow. As a 
consequence a compensatory mechanism 
consisting in a dilation of the brain arterioles, 
takes place. This compensatory response is 
inefficient, because instead of increasing the 
blood flow, it generates an increased local 
pressure. This last effect can be seen during 
intracranial pressure monitoring through the 
increased appearances of A and B high 
pressure weaves of vascular origin [42]. (See 
diagram 2) 
A decreased intracranial compliance causes, 
as was already mentioned, a decreased 
arterial expansion, which ends up breaking 
down the Windkessel mechanism. This break 
down diminishes the diastolic arterial flow, 
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augments the intracranial arterial pulsatility 
and capillaries pulsations. All of these causes 
the expansion of the brain parenchyma [41], 
[44], [46]. This expansion occurs 
predominantly (as a vector force) centripedally 
inside toward the ventricles, since the inner 
surface of the brain (ventricular surface) is 
much smaller than its outer surface area, 
augmenting the intraventricular pulse 
pressure. The latter produces an increased 
transcranial pulsatile pressure. This increase is 
a consequence of the brain autocompression 
against the ventricular system during each 
systole, due to the fact that the brain 
parenchyma has a high plasticity while the 
CSF is incompressible. If we apply the latter to 
the Law of Pascal, it is assumed that the 
counterforce produced from the ventricles 
equals the force of brain expansion. As it was 
already mentioned, due to its high plasticity, 
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the brain does not regain completely its pre-
systolic volume during each diastole. This 
produces a cumulative effect of brain 
compression during each systole, which over 
time would explain a progressive and 
compensatory dilation of the ventricles. Some 
studies claim that a sign of the decreased 
compliance and of the increased pulsatile 
transcortical pressure is the progressive 
ventricular size enlargement [100]. 
The increase of the pulsatile transcortical 
pressure produces a compression of the 
intracranial vessels capacitance (brain and 
cortical veins, and brain capillaries), which as 
was already mentioned diminishes directly the 
intracranial compliance. Coming back to the 
sequence of the pathophysiological 
mechanism, we recognize that an increased 
intraventricular pulse pressure causes, 
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besides ventriculomegaly, two additional 
effects. 
The first one consists in a hyperdynamic flow 
of CSF at the aqueduct. Studies made with 
Cine phase-contrast MRI reported that in the 
cases of patients with symptomatic iNPH, the 
CSF ejection volume at the aqueduct level 
increases in time if the patient does not 
receive a CSF shunt [97], which would speak 
in favor of the mechanism being described. 
The second effect is a direct result of a 
decreased intracranial compliance, being 
therefore a way in which this mechanism 
suffers a positive feedback. It is important to 
mention that the decrease of the supratentorial 
compliance is greater than the one of the 
infratentorial compliance. This happens 
because the infratentorial space is closer and 
in direct communication to the spinal dural sac, 
which has a high compliance and in turn helps 
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to compensate the compliance decrease at 
this level. 
This would explain the reason why in 
communicating hydrocephalus, the 
ventriculomegaly is lesser or even does not 
exist under the tentorium [42]. It must be said 
that in spite of the decrease of brain blood 
flow, which produces a diminished CSF 
absorption, the hydrodynamic theory attributes 
the ventriculomegaly to the consequences of 
the decreased compliance and the increased 
intraventricular pulse pressure. However, it is 
not clear if this diminished absorption at the 
brain capillary level plays any role in regard to 
the ventricular enlargement, which is what has 
been claim for the last five decades. (See 
diagram 3). 
In short, in order to stress the role of the 
vascular disorder at the pathophysiological 
origin of iNPH, the hydrodynamic theory 
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proposes the following terms: “restricted 
arterial pulsation hydrocephalus or increased 
capillary pulsation hydrocephalus”. On the 
other hand, this pathophysiological mechanism 
would explain the reason why there is 
temporary clinical improvement after the CSF 
evacuation during the diagnostic lumbar 
puncture and also why there is permanent 
clinical improvement after the CSF shunt, after 
the endoscopic ventriculostomy of the third 
ventricle, and after the decompression of the 
posterior fossa in those cases in which 
hydrocephalus is caused by the obstruction of 
the CSF pulsatile flow at the level of the 
foramen magnum. 
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Diagram 2 
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Diagram 3 
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Clinical diagnosis 
In relation to clinical diagnosis, iNPH is 
characterized by the Hakim-Adams typical 
symptomatic triad [49]. The classic triad 
consists of: walking disorders, cognitive 
disorders and urinary incontinence. These 
symptoms usually appear in the order in which 
they were named. This is the most frequent 
way in which the sickness appears, but there 
are some cases in which this sickness 
presents itself in a way that does not follow the 
classic pattern [39]. This symptomatic triad is 
not pathognomonic for iNPH, given the fact 
that it appears in other subcortical dementias, 
like those with a vascular origin, and the 
Alzheimer disease, which is cortical dementia. 
The clinical forms are the following: typical, 
atypical, incomplete and mixed [89], [90]. 
Some series show that these patients have a 
worse response in relation to a CSF shunt and 
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in the case of a clinical improvement, this 
happens only regarding the walking disorders 
and urinary incontinence [98], [111].  
In relation to the presentation frequency of 
clinical symptoms, the complete triad appears 
in approximately 50% of the patients. Walking 
disorders is the most frequent clinical 
manifestation, because as the only symptom it 
is present in approximately 10% of the 
patients; as a symptom associated to cognitive 
disorders is present in approximately 30% of 
the patients; and as a symptom associated to 
urinary incontinence it is present in 
approximately 7% of the patients. Likewise, we 
know that in order of frequency follow the 
cognitive disorders, which are present as the 
only symptom of the disease in approximately 
2% of the patients, and as an associated 
symptom to urinary incontinence in 
approximately 3% of the patients. At last, the 
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urinary incontinence appears as the only 
symptom in approximately 0,3% of the patients 
[23], [91]. Traditionally, the iNPH 
symptomatology has been related to the 
alteration, first morphological, and then 
functional of the fascicles of the periventricular 
white matter (corona radiata). This alteration is 
caused by ventricle enlargement, which even 
with a normal pressure distends the corona 
radiata. This explains the fact that iNPH 
symptomatology is reversible by CSF 
shunting. In spite of this, it is known that on 
late stages of the disease, there is a no return 
point, i. e. despite surgical treatment, the 
patients highly suspected of suffering iNPH do 
not show any clinical improvement [64]. The 
distension of the limbic system, which is near 
to the lateral ventricles, could explain the 
cognitive and personality disorders [112]. In 
opposition to the latter, electromyographic and 
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motor evoked potential studies on patients 
possibly suffering iNPH, showed that motor 
disorders have a greater relation with 
extrapyramidal tracts than with pyramidal ones 
[117]. 
The hydrodynamic theory attributes the 
symptoms appearance to the decrease of 
intracranial compliance and of the brain blood 
flow [42] and likewise because of a CSF 
dynamic disorder [29]. Other studies say that it 
is frequent that there are changes in the 
periventricular white matter and the deep white 
matter, which also could explain the symptoms 
[108]. This could be related to the idea of the 
second hit theory [12], and as was already 
mentioned, it proposes that the aging and 
ischemia of the deep white matter could be 
responsible for the symptomatology present in 
iNPH [14] It is important to mention that this 
symptomatology presents great variations in 
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relation to the nature of the symptoms, the 
manner of presentation, severity and 
progression. Therefore, there is not a natural 
history of iNPH, which can be absolutely 
typified for its symptomatology [91]. 
Nevertheless, as has been said, the 
symptomatic triad describes it best, including 
in order (more frequent to less frequent): 
walking disorders [85], cognitive disorders and 
urinary incontinence. We will study them in this 
order. 
 
Walking disorders 
This is the most characteristic and prominent 
disorder related to iNPH. It is frequent to 
observe that the altered walking is 
accompanied by anomalous posture and a 
slowing down of all motor activities [8], [49]. In 
spite of the wide spectrum, it is found that at 
the initial phases of the disease appears a 
  63 
form of instability and equilibrium disorder. The 
patient shows difficulty to begin a walk or to 
make a turn, which causes a slowing down 
and difficulty to climb stairs. This is followed by 
a gait with widened base, the steps become 
faster and shorter and there is a dragging of 
the feet, which seems as if they were glued to 
the floor, for this reason it is said that they are 
attracted by some kind of magnetism 
(magnetic walk). There is also a degree of 
anterior flexion of the trunk and spasticity, 
which is more evident in relation to the lower 
limbs, and because of this there is frequent 
sensation of fatigue in the legs and an 
increase of rigidity regarding the lower limbs. 
There is neither ataxia nor paresis of the 
members [112]. Although beginning to walk is 
difficult, once the movement has begun the 
activity becomes progressively normal. This 
difficulty to begin movements can also be seen 
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in Parkinson´s disease [103], likewise 
bradykinesia, tremor, posture instability, 
walking retropulsion and festination, mask 
facies, rigidity with or without Cogwheel Sign, 
among others [92]. However the fact that the 
movement improves with time shows a frontal 
motor disorder. Another way to differentiate 
iNPH from Parkinson´s disease relates to the 
rigidity of lower limbs, which in the first case is 
minor and in the second serious, additionally 
there is a permanent slowness of alternating 
movements [24]. Finally, the patient loses the 
ability to turn in bed, to stand up and to walk 
around. 
 
Cognitive disorders and dementia 
The neuropsychological deterioration of iNPH 
varies greatly, because it involves cognitive 
and behavioral capabilities. Also the symptoms 
and the severity of them vary for each patient, 
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because their beginning is insidious and they 
could become acute due to systemic 
processes, for example viral diseases. On the 
other hand, most patients show minor 
symptoms which progressively become worse, 
therefore it would be hasty to classify from the 
beginning this neuropsychological 
deterioration as “dementia” [106], [109]. 
Although the symptoms are progressive and 
chronic, affect primarily the memory and later 
the behavior and thought, making it impossible 
to perform the activities of everyday life, 
language is generally not affected [24]. It 
represents a secondary dementia, because 
the cause of the mental disorder is the 
mechanical effect of hydrocephalus on the 
limbic system, corona radiata and frontal lobe, 
and not a primary functional cortical disorder. 
This is supported by the fact that the 
symptoms are reversible by CSF shunting, and 
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because of this it is classified as potentially 
reversible dementia [24]. Other authors also 
would classify it as secondary by attributing it 
causes as ischemia of deep white matter 
[108]. This kind of dementia is called also 
“subcortical dementia”, which shows 
pathological subcortical alterations that can 
affect the functions of the frontal lobe, and for 
this reason it is also called front-subcortical 
dementia. The subcortical dementia (for 
example iNPH) is characterized by motor 
disorders, dysarthria, depression and apathy, 
while cortical dementia is characterized by 
aphasia, apraxia and agnosia. The motor 
disorders help to differentiate the subcortical 
dementia (v. g. gait apraxia and iNPH tremor) 
from the cortical dementia [6], because in the 
former they represent a primary symptom and 
in the latter they appear in late stages of the 
disease [95], [99]. In relation to subcortical 
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dementia, after the motor disorders, appear 
the cognitive ones, which evolve 
simultaneously [35]. The cognitive deterioration 
begins generally with a slight intellectual 
slowing down (decreased attention and 
concentration) and an insidious loss of recent 
memory. This is followed by a deterioration of 
the information processing speed, executive 
functions ability, visuoconstructive and 
visuoespatial abilities, the capability to perform 
complex calculations and abstract processes, 
it also can appear micrographia and lastly 
there is an accentuation of memory 
deterioration which goes even to falsification of 
memories (fabulations) [4]. 
 
Sphincter incontinence 
This is the least frequent symptom and the one 
that often appears the latest. If it appears as 
first symptom, it is normally attributed to 
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urological or gynecological disorders, because 
normally it refers to old patients as well. At the 
beginning, its presence is thought to be 
caused by the dilation of the corona radiata 
with affectation to motor system, however, at 
late stages of iNPH it can be associated to 
neuropsychiatric deterioration and because of 
this, it is called frontal lobe incontinence, given 
the fact that it seems that the patient does not 
care about the incontinence [112]. Generally, 
its beginning is insidious and the patients 
describe it as an imperious need to urinate 
(urinary urgency) or simply as frequent 
micturition (pollakiuria). There can be different 
degrees of incontinence, which can become 
continuous incontinence or frontal lobe 
incontinence. Some studies make references 
to cases in which anal sphincter incontinence 
appear at final stages of iNPH [4]. 
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Paraclinical diagnosis 
Radiological diagnosis is a key feature in 
relation to iNPH. Along the years, tests like 
MRI and CT have become essential tools in its 
diagnosing and monitoring. Additionally, these 
tests have helped to understand the 
morphological changes of iNPH, to relate them 
to the clinical characteristics of the disease 
and to explain its pathophysiology. However, 
in recent years and due to technological 
progress, the radiological tests, especially 
MRI, have been used in very promising ways. 
We are speaking of functional radiology, where 
through quantification of images with phase-
contrast [33], through the use of biological 
markers [107], among other techniques, it has 
been possible to learn the dynamic between 
intracranial fluids and the spaces containing 
them. This has provided a greater certainty in 
differential diagnoses and also in relation to 
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the prognosis regarding the patients who 
received a CSF shunt. As has been already 
said, the diagnosis of iNPH tends to be 
unclear. It is not easy to establish a differential 
clinical diagnosis between iNPH and dementia 
multi infarct, Alzheimer type dementia and 
Parkinson´s disease. Because of these, 
research endeavours try to establish means of 
characterizing them [97]. It should not be 
forgotten that MRI cannot be used on patients 
with metallic implants or who are 
claustrophobic, besides it is more expensive. 
Nevertheless MRI is preferred for the primary 
study and diagnosis of iNPH, and it is 
considered that CT is a good radiological 
mean for the postsurgical monitoring of 
patients. MRI shows a high sensitivity 
regarding the brain tissue, besides it provides 
the possibility of a better evaluation of the 
posterior cranial fossa and ventricular 
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narrowing (foramina of Monro, the median 
aperture and the lateral recess of the fourth 
ventricle), also it allows to visualize the CSF 
dynamic, which in iNPH patients is 
hyperdynamic. This hyperdynamic flow is an 
indicator of positive prognosis in case of a 
CSF shunting, but the fact that it does not 
exist, does not preclude the existence of iNPH 
[31].  
The image tests (CT or MRI) should be done 
in order to confirm the ventricular enlargement, 
to rule out obstructive causes of this 
enlargement and also rule out brain atrophy or 
false hydrocephalus (ex vacuum). Besides, 
through these tests it can be seen the 
morphology of the ventricular system and brain 
parenchyma. Morphological changes like 
lateral ventricles enlargement, with a round 
contour of its frontal horns, a corpus callosum, 
which is flatten and cranially displaced against 
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the falx cerebri, a round third ventricle bulging 
toward its floor or exhibiting dilation of its 
anterior and posterior recesses, and a less 
dilated fourth ventricle are frequently 
associated with iNPH. There is also in iNPH a 
greater dilation of the temporal horns, which 
helps to differentiate it from brain atrophy [42], 
[54]. The Evans index should be quantified 
[32]. This index should be equal to or greater 
than 0,3 in iNPH cases. It reflects the 
increased rate of ventricular size in relation to 
the diameter of the cranium [91]. The presence 
of a periventricular edema is due, according to 
the hydrodynamic theory, to the fact that the 
greater transcortical pulsatile pressure acts on 
the ventricular wall and also that this pressure 
is stronger at the horns of the lateral ventricles, 
which would explain the presence of edema in 
these places. As was already mentioned in 
regard to the pathophysiological mechanisms, 
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this theory explains phenomena like the 
dilation of the lateral sulcus (Sylvian fissure), 
the presence of subarachnoid cysts, because 
they both are located near the great brain 
arteries, and that the fourth ventricle does not 
appear with a clear size increase, because its 
proximity to the spinal sack, which has a high 
compliance [42].  
 
Treatment 
To speak about the iNPH treatment is not 
simple [17], [67], given the fact that there are 
some aspects related to it which are not clear. 
In other words, not being clear the 
pathophysiological mechanism which explains 
it, the symptomatology that characterize it and 
the radiological findings that describe it, also it 
is not clear the natural history that defines it 
and much less the way to treat it [18], [50], 
[66]. Thus when we encounter a patient, whom 
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we suspect of suffering iNPH, there remain 
always questions without answer like: is it 
really iNPH? and if it is, is the patient already 
at the point of no return?; if he is operated, will 
he improve and how great will be that 
improvement? On the other hand, iNPH 
involve persons of old age with more than one 
comorbidity factor characteristic of their age, 
which could make the surgical act as such and 
the possible postsurgical complications even 
more riskier for the patient than the normal 
symptomatic progression of the disease [55]. 
The ventriculoperitoneal shunt is the most 
used [9]. The risk of CSF hypodrainage 
depends on the conditions of the abdominal 
cavity. Excluding this one, the most usual 
complications, common to all ventricular 
systems, are CSF hyperdrainage (cephalalgia, 
chronic subdural hematomas and subdural 
hygromas), the ones related to a foreign body 
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implantation (bleeding, infections, catheter 
obstruction and dislocation) and the ones 
related to a malfunction of the valve system 
(valvular siphonage and damage) [92]. The 
type of valve recommended for iNPH is a 
debated subject [69], [80]. However, there is 
some consensus in preferring the use of 
adjustable valves, which allow establishing low 
pressures. In case of siphonage, it is 
recommended the use of additional 
antigravitational and anti-siphon devices [92], 
[90]. The hydrodynamic theory, based on its 
pathophysiological proposal, offers not only 
the CSF shunt as a possible treatment, but 
also the third ventricle ventriculostomy [37], 
[36] and the posterior fossa decompression as 
surgical measures against iNPH [42]. These 
three surgical procedures can theoretically 
eliminate the cause of iNPH, in case they 
normalize both the hemodynamic conditions of 
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the nervous system and the CSF flow, which 
at the end restores the intracranial compliance. 
This is another unanswered question by the 
CSF bulk flow theory, given the fact that it 
cannot explain the reason why both the 
posterior fossa decompression and the 
ventriculostomy of the third ventricle can 
improve the clinical symptoms and the 
radiological findings, and none of these 
procedures intervene with the absorption of 
CSF at the arachnoid villi. After the CSF shunt, 
the brain veins that were compressed re-dilate, 
which increases the intracranial compliance, 
thus arterial pulsation decreases, the venous 
resistance diminishes and the brain blood flow 
increases. In the case of a ventriculostomy of 
the third ventricle, an opening on the floor of 
this ventricle is created surgically. This 
communicates the CSF flow between the 
ventricular system and the subarachnoid 
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space. This communication increases the CSF 
ejection from the ventricle in each cardiac 
systole, which decreases the intraventricular 
pulse pressure. This decreased intraventricular 
pulse pressure diminishes the transcortical 
pulsatile pressure, which in turn diminishes the 
ventricular size and secondarily allows the 
expansion of the cortical veins and of the 
subarachnoid space. As has already been 
seen, the expansion of the cortical veins 
increases the intracranial compliance, 
diminishes the venous resistance and restores 
the brain blood flow.  
 
 
3 Part II - Clinical Investigation 
3.1 Research Questions 
This doctoral thesis in addition to summarizing 
and reviewing dynamic pathophysiological 
mechanisms that might explain iNPH - tries to 
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contribute to the establishment of a diagnosis 
and treatment protocol regarding those 
patients, who are suspect of suffering from 
iNPH. As has been said in part I, even if there 
are at least two components of the Hakim’s 
triad present and the radiological findings 
comply with ventriculomegaly, there is at least 
a 30% chance of non-improvement after shunt 
treatment. Furthermore, if only one symptom 
of the triad is present, there is much less 
certainty regarding the clinical improvement 
after the CSF shunt. The placement of a CSF 
shunt valve implies important risks of 
complications however, both in the short and 
long run, which have the potential not only to 
decrease the quality of life of patients, but 
being life threatening. For this reason, clinical 
and radiological findings are supplemented - 
especially in cases of possible iNPH  - by 
additional diagnostic procedures. One 
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approach is computerized overnight monitoring 
and recording of intracranial pressure (ICP), 
which tries to identify the disease through the 
interpretation of the physiological and 
pathophysiological ICP dynamics. The second 
approach is computerized ICP recording 
during a lumbar infusion study (volume 
challenge) and interpretation of the resulting 
ICP increase.  
Therefore, this work will try to relate the role of 
computerized analysis of intracranial pressure 
and cerebrospinal fluid dynamics to the 
diagnosis of idiopathic normal pressure 
hydrocephalus and investigates the effect of a 
positive response after three days lumbar 
drainage on the intracranial pressure derived 
variables. Finally, the outcome result 6 months 
after shunt implantation will be related to the 
initial findings.  
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In keeping with the hydrodynamic theory of 
hydrocephalus where a low compliance is in 
the core of the pathophysiological framework 
we hypothesize that our patient cohort will 
show indices of decrease compliance in 
overnight monitoring and lumbar infusion 
study.  
The second hypothesis is, that a three day 
lumbar drainage trial resulting in a clinical 
improvement of the patient will also result in an 
improvement of parameters in the sense of an 
improved craniospinal reserve capacity and 
compliance. 
 
3.2 Methodology 
This used data set comes from a retrospective 
analysis that covers a 30 months period (from 
November, 2008 to May, 2011). From all 
patients who were evaluated for the diagnosis 
of probable or possible iNPH only those 
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patients were selected for this thesis who 
fulfilled the below named inclusion criteria, 
received the full clinical evaluation protocol 
plus computerized overnight monitoring of 
intracranial pressure, plus a lumbar infusion 
test, plus three days lumbar drainage protocol. 
From this cohort only those are included in this 
thesis who were classified as possible shunt 
responders, received a VP shunt in 
consequence and had a full clinical follow-up 
six months postoperatively. 
 
Sample 
This highly selected patient cohort comprises 
21 patients The actual number of patients 
seen, evaluated and if positive during tests 
treated for iNPH was much higher (> 100 
patients). However, all others either did not 
meet all inclusion criteria for this analysis or 
had received clearly positive spinal tap tests in 
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outside departments or institution, identifying 
them as possible shunt responders. This latter 
group of patients was treated by VP shunt 
insertion right away and not subjected to the 
extended protocol described below.  
This protocol was applied to patients with 
uncertain or negative result of a simple spinal 
tap test applied elsewhere. Furthermore it was 
applied as standard of care to all patients who 
presented initially at out institution with 
suspected iNPH.  
 
Inclusion criteria 
- Presenting at least two of the symptoms 
of the Hakim triad, one of them had to 
be gait disorder. 
- Imaging that confirms ventriculomegaly 
(Evans index >0,3) and rules out any 
other obstructive process. 
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- Suspicion of iNPH, not associated to 
infection, hemorrhage, surgery or 
previous trauma. 
- Absence of any sensor-motor disability 
(visual, auditory, etc.) that prevents the 
patient from fulfilling the clinical 
evaluation of the protocol. 
- Absence of another type of dementia. 
- Completion of the full clinical evaluation 
protocol and thereafter placement of 
ICP sensor, ICP monitoring for at least 
24 continuous hours before the lumbar 
infusion test. 
- Insertion of lumbar drain and lumbar 
infusion study. 
- CSF drainage for 48 - 72 continuous 
hours and under simultaneous and 
continuous monitoring of intracranial 
pressure. 
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- Clinical evaluation immediately after 
removing the lumbar drainage and the 
intracranial ICP sensor. 
- Identification of possible responder:  
 A) Clinical improvement in walk 
test or pegboard test of ≥  10% plus 
subjective improvement according to 
patient or relatives.  
 B) Clinical improvement in walk 
test or pegboard test of 5-10% plus 
subjective improvement plus one of the 
following values of the supplemental 
tests: initial overnight monitoring: mean 
RAP >0,6, or mean AMP > 1 mmHg, or 
Rout > 13 mmHg*min-1 or PVI <15 ml, or 
E > 0,15 1/ml. 
- Ventriculoperitoneal shunt system 
inserted between 4 to 8 weeks after 
evaluation. 
- Clinical re-evaluation at 6 months. 
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Materials and Methods 
This study includes two sets of diagnostic 
tools, which were used  
1) a clinical evaluation and  
2)  computerized monitoring of intracranial 
pressure at rest, under lumbar infusion test 
and after lumbar drainage. 
 
Clinical Evaluation 
All patients were evaluated at the 
hydrocephalus outpatient clinic of the 
Department of Neurosurgery at the Tübingen 
University Hospital, where it was confirmed 
that they fulfilled the inclusion criteria of 
possible or probable iNPH. After admission to 
the hospital, the full clinical evaluation protocol 
was performed. 
The protocol consists of: determination of the 
comorbidity index, the modified scale of Kiefer, 
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gait evaluation, the Pegboard Test and the 
Mini Mental Test. The comorbidity index was 
used only once, at the moment of admission. 
The modified scale of Kiefer was used twice 
(1) before the evaluation and (2) at the 6 
months follow-up control after CSF shunt 
placement. The gait evaluation, the Pegboard 
Test and The Mini Mental Test were applied 
three times, (1) before evaluation (2) after the 
lumbar catheter had drain at least 500 ml of 
CSF in a period of no less than 48 continuous 
hours, and (3) at the 6 month follow-up visit 
after ventriculoperitoneal shunt placement. 
 
Comorbidity index (CMI): It was determined in 
the initial questioning. The CMI was introduced 
by Kiefer [61]. It represents a tool for different 
pathologies and their relation with the iNPH 
[76]. The CMI establishes the existence of 
known cerebrovascular disease, disease of 
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heart or the peripheral vessels (including 
hypertension) and as a systemic risk factor 
diabetes mellitus. Lemcke [68] et al. reported 
that the comorbidity factors are a statistically 
significant predictor of the quality of the clinical 
outcome for these Patients. The greatest value 
is 23 points, which corresponds to a patient 
that has a disease associated to all areas that 
are covered by this index. The inquiries about 
these factors are made only once, they are not 
evaluable by physical examination and they 
belong to the clinical history of the patient. 
 
Modified Scale of Kiefer [60]: (Homburg-Scale 
according Kiefer and Steudel) This scale 
allows the evaluation of all symptoms that 
characterize iNPH. Additionally, it considers 
other symptoms like headache and vertigo. 
These two might also be present in iNPH. The 
greatest value is 29 points, for patients with a 
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high degree of disability and dependence. The 
best value is 0 points, which corresponds to 
asymptomatic individuals. Value above 8 
points in the initial evaluation is considered a 
good predictive response factor for patients 
with iNPH. Using the Kiefer Scale it is possible 
to calculate the NPH recovery Rate [77]. It is 
calculated according to the equation: [(Kiefer 
Initial Value – Kiefer Value 6 Mo. after VP-
Shunt / Kiefer Initial Value) x 10]. The results 
are classified according to Black Grading 
Scale for Shunt Assessment [7]. An 
improvement ≥7 is considered as Excellent, ≥5 
as Good, ≥3 as Fair, ≥ 2 as Transient and <2 
as Poor. Values of the NPH Recovery Rate 
are expressed in Points. 
 
Gait Evaluation (number of steps in relation to 
time in seconds): Gait disorders are the 
predominant symptom of iNPH. The test 
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measures the number of steps and time in 
seconds that are needed for the patient to walk 
10 m. This is done three times in a row and 
then an average value is obtained. The lower 
the number of steps and shorter the time are, 
the more secure and fast the gait of the patient 
is interpreted to be. In our work, it is only taken 
into account as a control measure the time in 
seconds. 
 
Grooved Pegboard Test [105]: This test 
belongs to the protocols of neuropsychological 
evaluation in psychogeriatrics. It is one of the 
principal tests in order to evaluate the visuo-
spatial and visuoconstructive perception, 
besides being a test of medium level cognitive 
demand. It evaluates the hand skill that 
requires complex motor-visual coordination [4]. 
It is a test of handling dexterity that consists of 
a board with 25 holes with random oriented 
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excavations and the pegs are to be inserted in 
order from left to right and from above to 
below. The evaluation measures the time in 
seconds required to accomplish the task. 
Using the dominant hand, it is considered 
normal for patients between 50 and 59 years 
of age to complete the task in 68,10 seconds 
(SD: 9,42 seconds) and for patients older than 
60 82,70 seconds (SD: 18,70 seconds). 
 
Mini Mental Test (Mini Mental State 
Examination - MMSE) [105], [34], [4]: This test 
was used because of its brevity and simplicity 
in order to make a neuropsychological 
evaluation. Besides, it is of easy application 
and widely used by physicians. Despite the 
fact that it does not define adequately the early 
cognitive alterations in NPH, it has been 
included in this study, because it provides a 
fast and global measure of the cognitive 
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alteration´s severity and allows to quantify the 
patient´s degree of cortical dementia. The 
greatest value is 30 points and if the score is 
lower than 24, it indicates the presence of 
dementia. 
 
Intracranial pressure monitoring  
Intracranial pressure monitoring (initial, lumbar 
infusion test [58] and lumbar drainage) [99]: 
must be defined as a concept of ICP 
visualization, control and data recollection 
method. ICP was monitored continuously. 
These data allow to analyse and interpret 1) 
the time course and dynamics of the mean 
intracranial pressure (ICP), the ICP amplitude, 
the correlation index of mean intracranial 
pressure and pressure amplitude (RAP) which 
is related to the cerebrospinal reserve capacity 
or compliance and the magnitude of ICP slow 
wave (SLOW).  
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The lumbar infusion test is a diagnostic test, 
which provides data regarding Elastance (E) 
and Volume Pressure Index (PVI) of the 
intramural (intraspinal and intracranial) 
compartment and a measure of CSF outflow 
resistance (Rout) [102]. CSF drainage of 30-50 
ml by an isolated lumbar puncture (spinal tap 
test) has been traditionally used to assess - 
besides CSF pressure - the response to 
shunting. However, it could be shown, that a 3 
days lumbar CSF drainage protocol via a 
lumbar catheter has a higher predictive value 
regarding shunt response and is considered 
the gold standard [91]. 
In this study, an intracranial and 
intraparenchymal ICP sensor (Neurovent-p, 
Raumedic AG, Helmbrechts) was placed 
under local anesthesia at the Kocher´s point 
[40]. Later the intracranial sensor was 
connected to the Raumadic Datalogger MPR1 
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monitor to initiate the ICP recording. The 
MPR1 was connected via USB to a computer, 
were ICP data were online sampled by ICM + 
monitoring software (Cambridge University 
Enterprise, Cambridge, UK).  
The ICP monitoring was performed for at least 
a complete night before conducting the lumbar 
infusion study, which took place after a lumbar 
drain was placed under local anesthesia.  
The patient is warned about possible 
inconveniences during the test and that in 
case of strong headache or neck pain, he 
should notify it immediately in order to 
suspend the test. Then the patient was 
positioning supine in the bed for 15 minutes, 
staying calm, not speaking and not moving. 
Baseline ICP recording was done for 15 
minutes. Thereafter an infusion of Ringer 
solution through the lumbar drain at a rate of 
1.5 ml per minute was started. The infusion 
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was terminated if the ensuing ICP increase 
resulted into a new equilibrium with a new ICP 
plateau for at least 10 minutes. A premature 
termination was performed if the patient 
became symptomatic or if the intracranial 
pressure increased over 40 mmHg. After 
termination of the lumbar infusion, ICP 
recording continued for further 10 minutes.  
Thereafter CSF was drained at a rate of 7 - 8 
ml per hour for 48 to 72 hours. By this means it 
simulates the patient having a CSF shunt.  ICP 
recording was contused during the nights. 
After confirming that 500 ml had been drained, 
both the intraparenchymal ICP sensor and the 
lumbar drain were removed under local 
anaesthesia.  
Finally, the clinical evaluation protocol (gait 
evaluation, Pegboard Test and Minimental 
Test) was applied again.  
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After analyzing the clinical and monitoring 
results, a decision was made if the patient was 
considered a responder (improvement in 
quantitative tests by 15%) and a shunt 
treatment should be offered. In this case they 
received a VP-Shunt and were monitored 
using the same protocol of clinical tests 6 
months after surgery. Those patients without a 
clinically improvement (<15%) were classified 
as non-responders and were informed that the 
chance of long-term improvement would be as 
low as 25% according to the results of 
Marmarou [73], [74] and the recommendation 
for a shunting procedure was weak. 
The responder patient was discharged with an 
appointment for a CSF shunt placement in the 
following 4 to 8 weeks. 
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Values and interpretation of monitoring  
The software sampled the ICP signal at a rate 
of 100Hz and calculated mean values per 
minute. On the basis of this AMP, SLOW and 
RAP were calculated. During infusion studies 
mean values were calculated every 10 s [21], 
[102], [115]. Values of continuous monitoring 
were assed only overnight during sleep from 
11 pm to 6 am to minimize positional and 
movement artifacts and to discover nocturnal 
ICP dynamics in response to vasogenic 
pressure waves during REM phase of sleep. 
 
Intracranial Pressure (ICP): it is the result of 
the circulatory dynamics between intracranial 
CSF, and blood. It is represented through the 
formula: ICP = ICPCSF + ICPvascular. Both 
components are dynamic and multifactorial. 
ICPCSF could be represented as the sum of the 
resistance to the CSF outflow multiplied by its 
  97 
formation volume and the sagittal sinus 
pressure [10], [86]. It is considered that the 
ICPvascular depends on factors like 
autoregulation, arterial pressure and blood 
outflow through the veins. In iNPH the ICP is 
normal or slightly elevated. Its value during the 
monitoring should be initially <15 mmHg. 
 
Amplitude (AMP): it is the ICP pulse amplitude, 
normally it increases simultaneously with 
intracranial pressure increase [87]. It can be 
assessed as diastolic - systolic ICP amplitude 
and analyzed over time (time domain method). 
This way of calculation pulse by pulse is 
complex and prone to artifacts and was not 
used by our software. Here, the so called 
frequency domain method was used, where 
amplitude was calculated as the first harmonic 
after Fourier transformation of the ICP signal, 
relating to the heart beat component of the 
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intracranial pressure wave and called AMP 
[21]. When baseline AMP during sleep is 
elevated >1 (corresponding to a diastolic-
systolic amplitude of > 3,5-4 mmHg), there is a 
suspicion of decrease in intracranial 
compliance. 
 
RAP Index: The RAP index (correlation 
coefficient [R] between the pulse amplitude [A] 
and the mean intracranial pressure [P]) [62], is 
derived by linear correlation between 40 
consecutive, time-averaged data points of 
pulse amplitude of ICP (AMP) and mean ICP, 
acquired within a 6 second-wide time-window. 
RAP describes the degree of correlation 
between AMP and mean ICP over short 
periods of time (~ 4 minutes). Theoretically, 
the RAP coefficient indicates the relationship 
between ICP and changes in intracerebral 
volume - the ‘pressure-volume’ curve. RAP 
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coefficient close to 0 indicates a lack of 
coupling between the changes in AMP and the 
mean ICP. This denotes a good pressure-
volume compensatory reserve, i.e. the 
‘working range’ is still in the horizontal part of 
the curve. When the pressure-volume curve 
starts to increase exponentially, AMP co-varies 
directly with ICP and consequently RAP rises 
to a maximum of +1. This indicates a low 
compensatory reserve [115], [63]. 
 
Slow intracranial pressure waves (SLOW): 
they are the result of changes in brain blood 
volume with a period of 20s to 2 min [63]. They 
are also called Lundberg B waves [72]. They 
are thought to be related to the metabolism of 
brain tissue, because they are associated to 
the fluctuation of blood brain velocity flow and 
arterial pressure. If there is presence of these 
curves in more than 80% of the monitoring 
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taken place when sleeping, the placement of a 
CSF shunt is recommended [89].  
 
The software, using spectral analysis (Fourier 
transform) calculates a variable, representing 
the equivalent amplitude (i.e. the amplitude of 
a sine wave bearing the same energy) of the 
slow waves, ‘SLOW’ [21]. 
 
Values and interpretation of lumbar infusion 
study [21] [115] 
CSF outflow resistance (Rcsf): is calculated as 
the difference between the value of the plateau 
pressure (during infusion) and baseline 
pressure, divided by the infusion rate Normal 
value: (>10 - <13 mmHg/(ml/min). Elevated 
Rcsf (>13 mmHg/(ml/min) denotes disturbed 
CSF circulation typically for iNPH [11], [12]. 
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Elastance (E): describes the rigidity of the 
cerebrospinal system, which is determined by 
the capability to displace a volume of 
cerebrospinal blood. It is an unspecified value, 
that in iNPH ranges between >0,10 and <0,15 
l/ml. 
 
Pressure volume index (PVI): it is the volume 
amount that has to be administered in order to 
duplicate the intracranial pressure average. If it 
is under 15 ml (<15 ml), it means that the 
adaptability is diminished and there is the 
suspicion of iNPH. 
 
 
3.3 Data management and Statistical Analysis 
The data of the initial clinical evaluation, the 
clinical evaluation after 3 days lumbar 
drainage and from the intracranial pressure 
monitoring and the lumbar infusion test were 
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recorded anonymously in an Excel table, 
designed according to that purpose. Results of 
the clinical evaluation at 6 months after the 
VP-Shunt implantation were added later.  
Finally, the data from the clinical response 
both after the lumbar drainage and after six 
months of the CSF shunting were compared to 
the initial clinical evaluation. 
In order to test the hypotheses all indicated 
statistical tests will be discussed in the 
following section. To describe the variables 
and their distributions, tables and graphics 
were used such as bar charts, histograms, pie 
charts and box plots. 
Considering the small number of cases (21 
patients) and the distributions of the variables 
all analyses were based on non-parametric 
models. Parametric methods like t-Tests and 
the Pearson correlation demand specific 
assumptions, which are not met in this study, 
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especially because of the number of cases as 
well as the assumption of normality and equal 
variances between samples. Therefore only 
non-parametric statistical tests have been 
used [13]. 
To examine the differences between the 
clinical tests and monitoring parameters a 
repeated measurements design has been 
used. There were different points of time when 
the tests were conducted and the parameters 
were measured, which refers to dependent 
samples. To test for significance when only 2 
dependent groups (e.g. initial vs. After VP-
Shunt) were involved, the Wilcoxon signed-
rank test was used. In case of testing 3 
dependent groups (e.g. initial vs. during 
Lumbar Infusion vs. after VP-Shunt) the 
Friedman-Test was the indicated statistical 
method. When the Friedman-Test showed a 
significant result, post-hoc tests in the form of 
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pairwise comparisons have been conducted to 
investigate which groups differ significantly. To 
avoid the cumulation of Type I error, caused 
by multiple testing, the p-values were adjusted 
using the Dunn-Bonferroni method [27]. 
Additionally the descriptive statistics to 
accompany the tests like minimum, maximum 
and the quartiles, were also calculated and 
presented in the output. 
To test for the relations between variables the 
correlation coefficient Spearman’s Rho was 
used. The correlation coefficient can range 
from-1 to +1, where 0 stands for non-related 
variables. A value higher than 0 (or positive) 
shows a positive correlation, a negative value 
shows a negative correlation. Values of -1 or 
+1 would show perfect correlation [19] 
suggested the following effect-sizes for a 
correlation: 
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< 0,1 no effect 
0,1 - 0,3 small effect 
0,3 - 0,5 medium effect 
> 0,5 large effect 
Therefore, the starting or (null) hypothesis 
(H0), assumes that the improvement of these 
patients after the VP-Shunt implantation is not 
significant, and second, the probable or 
alternative hypothesis, assumes that the effect 
of the treatment is significant (H1). Due to the 
fact that all hypotheses regarding correlations 
were one directional all correlations were 
tested one-sided. For all statistical tests a 
significance level (α-level) of p=0,05 was 
determined. If a result shows a p-value > 0,05 
the test is not significant and therefore the 
alternative hypothesis cannot be supported 
and the null hypothesis has to be retained. If a 
result shows a p-value ≤ 0,05 it is a statistical 
significant result and the alternative hypothesis 
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can be supported while the null hypothesis will 
be rejected. In detail we distinguish the 
following levels of statistical significance: 
p > 0,05 not significant 
p ≤ 0,05 significant 
p ≤ 0,01 very significant 
p ≤ 0,001 highly significant 
All analyses were conducted using Microsoft 
Excel 2010 and IBM SPSS Statistics Version 
22. 
It is important to mention, that in the SPSS 
Output the p-value is always called “Sig.” 
which stays for significance. Furthermore a p-
value of ,000 means always p < 0,001.  
 
 
4 Results 
4.1 Date. Table 1 
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4.2 Demographic Data  
Age Distribution (Years). Table 2 
 
 
 
Figure 1: Demographic Data: (Age Distribution) (Years) 
 
This figure 1 represents the demographic 
distribution of the sample in relation to the age. 
Of the 21 patients, who were parts of the 
study, we see that the mean age is 75,43 
years and the Standard Deviation (SD) is 6,50 
years. The mean and the median are very 
similar and they are between 70 and 80 years. 
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Sex Distribution. Table 3 
 
 
 
 
 
                                                             
Figure 2: Demographic 
Data: (Sex Distribution) 
 
This figure 2 represents the sex distribution of 
the sample. Of the 21 patients, who were part 
of the study, 11 are men and 10 are women. 
 
4.3 Clinical Data 
Clinical Evaluation (Kiefer Test / Points). Table 
4 
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Figure 3: Clinical Evaluation (Kiefer Test Initial / Points) 
 
  
Figure 4: Clinical Evaluation (Kiefer Test after VP-Shunt 
/ Points) 
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These figures 3 and 4 show the distribution of 
the Kiefer scale of the patients at the two 
moments at which it was applied during the 
study. A shift of distribution to the left at the six 
months post-operative control in relation to the 
initial evaluation indicates that there was a 
tendency to clinical improvement. 
 
Clinical Evaluation (Walk-Test / Sec.). Table 5 
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Figure 5: Clinical Evaluation (Walk Test / Sec.) 
 
The figure 5 shows the distribution regarding 
the Walk Test of clinical evaluation during the 
three moments of the study when it was 
applied. In this test there was clinical 
improvement both after the lumbar drainage 
and after the six months period following the 
VP-Shunt implantation. There was greater 
improvement after the lumbar drainage. It 
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should be noticed that the box-and-whisker 
diagrams divide the distribution in four parts of 
25% each. The plot as such keeps the 50% of 
data at the center, which is divided by a line 
that is the median. The figure 5 registers the 
extreme values of distribution marking with a 
little ball the patients that have results that are 
notoriously far of the rest.  
 
Clinical Evaluation (Pegboard-Test / Sec.). 
Table 6 
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Figure 6: Clinical Evaluation (Pegboard Test / Sec.) 
 
The figure 6 shows the distribution regarding 
the Pegboard Test of clinical evaluation during 
the three moments of the study when it was 
applied. In this test there was clinical 
improvement both after the lumbar drainage 
and the greatest improvement is seen at the 
six months control after the VP-Shunt 
implantation. 
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Clinical Evaluation (Minimental Test / Points.). 
Table 7 
 
 
 
Figure 7: Clinical Evaluation (Minimental Test / Points) 
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The figure 7 shows the distribution regarding 
the Minimental Test of clinical evaluation 
during the three moments of the study when it 
was applied. In this test there was clinical 
improvement both after the lumbar drainage 
and after the six months period following the 
VP-Shunt implantation. It should be noticed 
that there was greater improvement after the 
lumbar drainage. 
 
Comorbidity Factors. Table 8. 
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Figure 8: Clinical Evaluation (Comorbidity Factors) 
 
This figure 8 shows distribution of comorbidity 
factors that the clinical history of each patient 
presents. The mean and the median are the 
same for this sample. 
 
4.4 Intracranial Monitoring Data 
Intracranial Overnight Monitoring (ICP / 
mmHg). Table 9 
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Figure 9: Intracranial Monitoring (ICP / mmHg) 
 
The figure 9 shows the behaviour of ICP 
during the study. As it was described when the 
variables are defined, it is expected for iNPH 
that baseline ICP be <15 mmHg. After the 
lumbar drainage the ICP was lower. The figure 
 ICP initial in mmHg ICP after Lumbar Drainage in mmHg 
N 
Valid 21 21 
Missing 0 0 
Mean 9,2086 4,0819 
Median 8,9800 4,0700 
Std. Deviation 4,80032 3,99988 
Minimum ,34 -2,10 
Maximum 19,96 13,60 
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9 shows the variation of the ICP values in the 
sample after the lumbar drainage in relation to 
the initial monitoring. It should be noticed that 
after the lumbar drainage in some patients the 
values decreased by up to almost 12 mmHg. 
 
Intracranial Overnight Monitoring (Slow / 
mmHg). Table 10 
 
 
 
Figure 10: Intracranial Monitoring (Slow / mmHg) 
 Slow initial in mmHg Slow after Lumbar Drainage in mmHg 
N 
Valid 21 21 
Missing 0 0 
Mean 1,4968 1,0171 
Median 1,4600 ,9200 
Std. Deviation ,51976 ,44964 
Minimum ,81 ,35 
Maximum 2,81 1,92 
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The figure 10 compares the distribution value 
of the B waves amplitude (SLOW). The value 
of the amplitude is considered pathological 
when the mean is >10 mmHg and it is 
interpreted as a bad prognosis value for iNPH 
if the amplitude value during the infusion test is 
>1,5 mmHg. It should be noticed that the 
waves during the initial monitoring are above 
this threshold and close to it after the lumbar 
drainage. The figure 10 shows the value 
variation of the B waves amplitude after the 
lumbar drainage in relation to the initial 
monitoring. 
 
Intracranial Overnight Monitoring (Amplitude / 
mmHg). Table 11 
 
 Amp initial in mmHg Amp after Lumbar Drainage in mmHg 
N 
Valid 21 21 
Missing 0 0 
Mean 2,1210 1,2915 
Median 2,0200 1,2200 
Std. Deviation ,68137 ,40826 
Minimum 1,17 ,45 
Maximum 4,13 2,06 
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Figure 11: Intracranial Monitoring (Amp / mmHg) 
 
This figure 11 shows through the distribution 
values and in a comparative way the 
behaviour of the AMP during the two moments 
of ICP monitoring. The mean of the initial AMP 
and after the lumbar drainage is (>1 and <2). 
In the variation of the AMP values for each 
monitoring phase (initial monitoring and after 
the lumbar drainage), it should be noticed that 
the proportionality in the behaviour of the 
values tends to be similar to the value variation 
of ICP. These both values (ICP and AMP) are 
very influential during this study. 
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Intracranial Overnight Monitoring (RAP Index). 
Table 12 
 
 
 
 
Figure 12: Intracranial Monitoring (RAP) 
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The figure 12 compares the distribution of the 
values of the RAP Index during the two 
evaluated moments at the monitoring. The 
RAP Index is the correlation coefficient 
between change of ICP and change of AMP. It 
should be noticed that the mean value during 
the initial monitoring (deep sleep phase) is 
>0,6 which reveals a lower compensatory 
capacity of the system. After the lumbar 
drainage the mean value is <0,6. It should be 
noticed that only four patients had initial values 
<0,6 and none <0,4.  
 
Intracranial Monitoring during Lumbar Infusion 
study (RCSF mmHg*min/ml). Table 13 
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Figure 13: RCSF calculated from lumbar infusion study) 
 
This figure 13 shows the total distribution of 
the values of the RCSF at the lumbar infusion 
study. Normal values are below 10 - 13, values 
>13 - <18 (mmHg/ml/min) are considered to 
represent moderate pathological elevation 
associated with a higher likelihood of clinical 
improvement after CSF diversion. Values > 18 
mmHG/ml/min are considered to be severely 
pathologic, associated with the highest 
likelihood of improvement. 
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Intracranial Monitoring during Lumbar Infusion 
study (Distribution in groups of RCSF in 
mmHg*min/ml). Table 14 
 
 
 
Figure 14: RCSF distribution in three groups 
 
The figure 14 shows the number of patients 
that presented values lower than 13 
mmHg/ml/min (12 Patients) and greater than 
18 mmHg/ml/min (4 patients). Values below 13 
are considered normal, above 13 elevated and 
above 18 highly pathological. 
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Intracranial Monitoring during Lumbar Infusion 
Study (Elastance in 1/ml). Table 15 
 
 
 
Figure 15: Elastance (calculated from Lumbar Infusion 
Study) 
 
This figure 15 shows the total distribution of 
Elastance values calculated by lumbar infusion 
test. The mean is 0,30 1/ml and 11 patients 
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are under 0,20 1/ml. Values below 0.1 1/ml are 
considered normal and above 0.15 1/ml are 
thought to represent significant compromise of 
compliance and cerebrospinal reserve 
capacity. 
 
Intracranial Monitoring during Lumbar Infusion 
Study (Distribution in groups of Elastance in 
1/ml). Table 16 
 
 
 
  
 
 
Figure 16: Elastance distribution in three groups 
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This figure 16 shows a classification of the 
distribution of Elastance calculated by lumbar 
infusion test. 4 Patients have values below 0.1 
1/ml (considered normal); 11 Patients have 
values above 0.15 1/ml (considered 
pathological and represent significant 
compromise of compliance and cerebrospinal 
reserve capacity).  
 
Intracranial Monitoring during Lumbar Infusion 
Study (PVI in ml). Table 17 
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Figure 17: Intracranial Monitoring during Lumbar 
Infusion Study: PVI distribution 
 
The figure 17 shows the total distribution of the 
PVI values (ml) in this sample during the 
lumbar infusion study. The mean is 13,75. 12 
Patients have a PVI < 15 ml and 9 Patients > 
15 ml.  
 
Intracranial Monitoring during Lumbar Infusion 
Study (Distribution in groups of PVI in ml). 
Table 18 
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Figure 18: PVI (distribution into two groups) 
 
The figure 18 shows the PVI values in ml 
regarding the studied sample. As it was 
already said, the pressure-volume index (PVI) 
is the quantity of volume that has to be 
administered in order to double the mean of 
ICP. If this index is lower than 15 ml, it is 
interpreted as a diminished compliance. The 
latter is considered as a predictive value 
regarding the clinical improvement after VP-
Shunt implantation. The sample shows that 
57% of the patients (12) presented values <15 
ml during the infusion test. 
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4.5 Additional Descriptive Statistics 
Improvement Index (Clinical Evaluation 6 
months after shunt implantation). Table 19 
 
 
 
Figure 19: Improvement Index (Clinical Evaluation) 
 
The figure 19 shows the Improvement Index in 
(%) regarding the three tests (Walk-Test / 
Pegboard Test / Minimental Test) at the six 
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months post-operative control in relation to the 
initial evaluation. The improvement index was 
calculated according to the equation: [(Test-
Initial Value – Test-Value 6 Mo. after VP-Shunt 
/ Test-Initial Value) x 10]. An improvement 
>15% was considered as Excellent, between 
10-15% as Good, between 5-10% as Fair and 
<5% as Poor. This last value includes all 
cases of clinical deterioration. The test with the 
greatest number of patients showing an 
improvement index >15% is the Pegboard 
Test with a total of 14/21 patients. The test 
with the greatest number of patients that 
showed no improvement (improvement index 
<5%) was the Minimental test with a total of 
11/21 patients. Regarding the Walk-Test half 
of the patients (11/21) showed an 
improvement index >15%. 
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NPH Recovery Rate – Improvement (Clinical 
Evaluation) [77]. Table 20 
 
 
 
 
Figure 20: NPH Recovery Rate - Improvement (Clinical 
Evaluation) 
 
The figure 20 shows the NPH recovery Rate. 
They are calculated according to the equation: 
[(Kiefer Initial Value – Kiefer Value 6 Mo. after 
VP-Shunt / Kiefer Initial Value) x 10]. 
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According to the Black Grading Scale for 
Shunt Assessment [7] (based on the clinical 
grading for NPH by Kiefer) in relation with the 
NPH Recovery Rate an improvement ≥7,5 is 
considered as Excellent, ≥5 as Good, ≥3 as 
Fair, ≥ 2 as Transient and <2 as Poor. The 
long term responses after the Shunt 
implantation shows that 12 patients scored as 
Poor (57%), 4 as Fair (19%), and 5 as Good 
(24%) in relation to the initial evaluaiton. There 
was no patient with a score ≥7,5, i. e., with an 
Excellent long term response. 
 
NPH Recovery Rate – Percentile Ranking 
(Clinical Evaluation). Table 21 
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NPH Recovery Rate – Responder / 
Dichotomization. Table 22 
 
 
After the NPH Recovery Rate dichotomization 
for Responder (>2) and Non Responder (≤2) 
this Table shows that the 57,1 % (12 Patients) 
had not responded according to this mode of 
outcome assessment. 
 
 
4.6. Inferential Statistical – Correlation 
(Hypothesis) 
(H1): There are differences in test-results 
(clinical evaluation and intracranial monitoring) 
between initial, after lumbar drainage and after 
6 months VP Shunt implantation when the 
patients responding to three days lumbar 
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drainage trial and show indices of lowered 
intracranial compliance and shunting primarily 
these patients leads to an increase in 
intracranial compliance and restoration for 
reserve capacity by removing CSF.  
(H0): There are no differences in Test-Results 
(Clinical Evaluation and Intracranial 
Monitoring) between initial, after lumbar 
drainage and after 6 months VP Shunt 
implantation in these patients. 
 
Correlation (NPH Recovery Rate and Clinical 
Evaluation). Table 23 
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This table shows correlation (according 
Spearman´s rho correlation) of differences of 
Test-results (Improvement Index of Walk Test, 
Pegboard Test and Minimental Test) after VP 
Shunt Implantation with NPH Recovery Rate. 
The Walk Test show a Significance: 0,095 and 
the Pegboard Test a Significance: 0,252. 
There is not a significant statistical correlation, 
this difference was no significant (p>0,05) and 
(H1) was rejected. About Minimental Test the 
significance is 0,032, this difference was 
significant (p≤0,05) and is accepted the (H1). 
 
Correlation (Comorbitity Factors and clinical 
evaluation). Table 24 
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This table shows correlation (according 
Spearman´s rho correlation) of differences of 
Test-results (Improvement Index: Walk Test, 
Pegboard Test and Minimental Test) and 
(NPH Recovery Rate) after six months of the 
Shunt implantation in relation to the 
Comorbidity factors (CMI). The correlation 
between CMI and NPH Recovery Rate and 
Walk Test have a Significance (p>0,05) and 
this difference was no significant, the (H1) was 
rejected. The correlation between CMI and 
Pegboard Test and Minimental Test have a 
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Significance (p≤0,01), the difference was very 
significant, the (H1) is accepted. 
 
 
Differences of Intracranial Monitoring Data 
(whole Sample) (Initial - after Lumbar Drainage). 
Table 25  
 
 
Differences: Intracranial Monitoring Data 
(Patients) (Initial - after Lumbar Drainage / 
after Lumbar Infusion Test). Table 26. 
 
These tables show the intracranial monitoring 
data for each patient (table 25) and differences 
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of the complete sample (table 26) regarding 
ICP, Slow, AMP and RAP at the three time 
points of the study. We calculated the 
difference between the initial night of 
monitoring in relation to the last night under 
lumbar drainage. 
 
 
Table 26. 
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Correlation (NPH Recovery Rate and changes 
after lumbar drainage in overnight monitoring). 
Table 27 
 
 
This table 27 shows correlation (according 
Spearman´s rho correlation) of NPH Recovery 
Rate in relation to the differences of 
Intracranial Monitoring results after lumbar 
drainage (ICP, Slow and AMP, RAP). The 
correlation between NPH Recovery Rate and 
all ICM parameters (ICP, Slow, AMP and RAP) 
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have a significance (p>0,05). This difference 
was no significant and the (H1) was rejected.  
 
 
Walk Test - Percentile Ranking (Clinical 
Evaluation). Table 28 
 
 
Walk Test - Friedman Test. Table 29 
 
Walk Test – Significance (Chi-Square). Table 
30 
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Walk Test Outcome – Pairwise Comparisons. 
Table 31 
 
 
 
Figure 25: Walk Test Outcome (Clinical Evaluation) 
 
These tables (28, 29, 30, 31) and the figure 25 
show the outcome regarding the significance 
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of the Walk Test at the three time points when 
this test was applied (Initial, after Lumbar 
Drainage and after VP-Shunt Implantation). 
The significance of these three time points 
together (Chi Square) was p<0,05, i. e. the 
difference was significant and the (H1) was 
accepted. In the relation between the three 
moments separated (Pairwise comparisons) 
the significance was p≥0,05 for the first 
relation (after Lumbar Drainage – after VP-
Shunt), i. e. the difference was not significant 
and (H1) was rejected. The others two 
relations (after Lumbar Drainage – Test Initial, 
and after VP Shunt – Test Initial) show a 
significance of p<0,05, i. e. the difference was 
significant and (H1) was accepted. The Figure 
25 shows the distribution in the outcome for 
the Walk Test. The best outcome is found after 
Lumbar Drainage. 
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Pegboard Test - Percentile Ranking (Clinical 
Evaluation). Table 32  
 
Pegboard Test - Friedman Test. Table 33 
 
Pegboard Test – Significance (Chi Square). 
Table 34 
 
Pegboard Test Outcome – Pairwise 
Comparisons. Table 35 
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Figure 26: Pegboard Test Outcome (Clinical Evaluation) 
 
These tables (32, 33, 34, 35) and figure the 26 
show the outcome regarding the significance 
of the Pegboard Test at the three time points 
  148 
when this test was applied (Test Initial, after 
Lumbar Drainage and after VP-Shunt 
Implantation). The significance of these three 
time points together (Chi Square) was p<0,05, 
i. e. the difference was significant and the (H1) 
was accepted. In the relation between the 
three moments separated (Pairwise 
comparisons) the significance was p≥0,05 for 
the relations (after VP-Shunt – after Lumbar 
Drainage, and after Lumbar Drainage – Test 
Initial), i. e. the difference was not significant 
and (H1) was rejected. The relation (after VP 
Shunt – Test Initial) show a highly significance 
of p<0,001, i. e. the difference was significant 
and (H1) was accepted.  Figure 26 shows the 
distribution in the outcome for the Pegboard 
Test. The best outcome is found after VP 
Shunt. 
 
  149 
Minimental Test - Percentile Ranking (Clinical 
Evaluation). Table 36 
 
Minimental Test – Friedman Test. Table 37 
 
Minimental Test – Significance (Chi Square). 
Table 38 
 
Minimental Test Outcome – Pairwise 
Comparisons. Table 39 
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Figure 27: Minimental Test Outcome (Clinical 
Evaluation) 
 
These tables (36, 37, 38, 39) and the figure 27 
show the outcome regarding the significance 
of the Minimental Test at the three moments 
when this test was applied (Test Initial, after 
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Lumbar Drainage and after VP-Shunt 
Implantation). The significance of these three 
time points together (Chi Square) was p<0,05, 
i. e. the difference was significant and the (H1) 
was accepted. In the (pairwise comparisons) 
the significance was p≥0,05 for the 
comparison (after VP Shunt – after Lumbar 
Drainage), i. e. the difference was not 
significant and (H1) was rejected. The other 
two companions (Test Initial – after Lumbar 
Drainage, and Test Initial - after VP Shunt) 
show a significance of p<0,05, i. e. the 
difference was significant and (H1) was 
accepted. The figure 27 shows the distribution 
in the outcome for the Minimental Test. The 
best outcome is found after Lumbar Drainage. 
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Intracranial Pressure (ICP) - Percentile 
Ranking (ICM). Table 40 
 
ICP – Friedman Test. Table 41 
 
ICP – Significance (Chi Square). Table 42 
 
ICP Outcome – Pairwise Comparisons. Table 
43 
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Figure 28: ICP Outcome (Intracranial Monitoring) 
 
These tables (40, 41, 42, 43) and the figure 28 
show the outcome regarding the significance 
of the Intracranial Pressure (ICP) at the three 
time points when this parameter was 
measured (Test Initial, during Lumbar Infusion 
Study and after Lumbar Drainage). The 
significance of these three time points together 
(Chi Square) was p<0,001, i. e. the difference 
was significant and the (H1) was accepted. In 
the relation between the three time points 
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separated (Pairwise comparisons) the 
significance was p<0.05 for the three relations 
(after Lumbar Drainage – Initial Test; after 
Lumbar Drainage – during Lumbar Infusion 
Study, and Initial Test – during Lumbar 
Infusion Study), i. e. the difference was 
significant and (H1) was accepted. The Figure 
28 shows the distribution in the outcome for 
the ICP.  
Slow - Percentile Ranking (ICM). Table 44 
 
 
Slow – Friedman Test. Table 45 
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Slow – Significance (Chi Square). Table 46 
 
Slow Outcome – Pairwise Comparisons. Table 
47 
 
 
Figure 29: Slow Outcome (Intracranial Monitoring) 
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These tables (44, 45, 46, 47) and the figure 29 
show the outcome regarding the significance 
of the Slow at the three time points when this 
parameter was measured (Test Initial, during 
Lumbar Infusion Study and after Lumbar 
Drainage). The significance of these three 
moments together (Chi Square) was p<0,001, 
i. e. the difference was significant and the (H1) 
was accepted. In the relation between the 
three time points separated (Pairwise 
comparisons) the significance was p<0,05 for 
the three relations (after Lumbar Drainage – 
Initial Test; after Lumbar Drainage – during 
Lumbar Infusion Study, and Initial Test – 
during Lumbar Infusion Study), i. e. the 
difference was significant and (H1) was 
accepted. The figure 29 shows the distribution 
in the outcome for the Slow. The best outcome 
is found after Lumbar Drainage. 
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AMP - Percentile Ranking (ICM). Table 48 
 
AMP – Friedman Test. Table 49 
 
AMP – Significance (Chi Square). Table 50 
 
AMP Outcome – Pairwise Comparisons. Table 
51 
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Figure 30: AMP Outcome (Intracranial Monitoring) 
 
These tables (48,49,50,51) and the figure 30 
show the outcome regarding the significance 
of the Amplitude (AMP) at the three time points 
when this parameter was measured (Test 
Initial, during Lumbar Infusion Study and after 
Lumbar Drainage). The significance of these 
three time points together (Chi Square) was 
p<0,001, i. e. the difference was significant 
and the (H1) was accepted. In the relation 
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between the three time points separated 
(Pairwise comparisons) the significance was 
p<0,05 for the three relations (after Lumbar 
Drainage – Initial Test; after Lumbar Drainage 
– during Lumbar Infusion Study, and Initial 
Test – during Lumbar Infusion Study), i. e. the 
difference was significant and (H1) was 
accepted. The Figure 30 shows the distribution 
in the outcome for the AMP.  
  
Kiefer Score- Percentile Ranking (Clinical 
Evaluation). Table 52 
 
Kiefer Score – Wilcoxon Ranks. Table 53 
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Kiefer Score Outcome. Table 54 
 
One sided Test: 0,084 / 2: p:0, 042 (The 
Hypothesis is unidirectional) 
 
Figure 31: Kiefer Score Outcome (Clinical Evaluation) 
 
These tables (52, 53, 54) and the figure 31 
show the outcome regarding the significance 
of the Kiefer Score at the two moments when 
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this test was applied (Test Initial and after VP-
Shunt Implantation). The significance 
(according Wilcoxon Signed Ranks Test) was 
initially p:0,084, but this hypothesis is 
unidirectional and this value can be divided by 
2 (p:0,042), i. e. p<0,05, i. e. the difference 
was significant and the (H1) was accepted. 
The Figure 31 shows the distribution in the 
outcome for the Kiefer Score. A better 
outcome is found after VP Shunt. 
RAP - Percentile Ranking (ICM). Table 55 
 
RAP – Wilcoxon Ranks. Table 56 
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RAP Outcome. Table 57 
 
 
Figure 32: RAP Outcome (Intracranial Monitoring) 
 
These tables (55, 56, 57) and the figure 32 
show the outcome regarding the significance 
of the RAP at the two time points when this 
parameter was measured (Test Initial and after 
Lumbar Drainage). The significance (according 
Wilcoxon Signed Ranks Test) was p<0,001, i. 
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e. the difference was significant and the (H1) 
was accepted. The Figure 32 shows the 
distribution in the outcome for the RAP. The 
best outcome is found after Lumbar Drainage. 
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5 Discussion 
The results comprise clinical tests applied to 
patients at the initial evaluation, after 3 days of 
lumbar drainage and 6 months after VP-Shunt 
implantation. Furthermore  the results ICP 
overnight monitoring and CSF dynamics 
during the lumbar infusion test are shown.  
This is a highly selected cohort of patients 
which either failed an initial spinal tap test at 
an outside institution or department or were 
recruited from the neurosurgical outpatient 
clinic. After 3 days lumbar drainage protocol 
those patients were considered for shunt 
therapy who either had a clinical improvement 
in walk test or pegboard test of ≥ 10% plus 
subjective improvement according to patient or 
relatives. Alternatively, patients were 
considered for shunt of their clinical 
improvement in walk test or pegboard test was 
5-10% plus subjective improvement plus one 
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of the following values of the supplemental 
tests was present, indicating an decrease in 
craniospinal compliance: initial overnight 
monitoring: mean RAP >0,6, mean AMP > 1 
mmHg, or Rout > 13 mmHg*min-1 or PVI <15 
ml, or E > 0,15 1/ml.  
Patients were only included into the analysis if 
they received a shunt within 4-8 weeks after 
testing, to make sure that the clinical status of 
the patients was still as recorded. In this aging 
cohort of patients a longer interval might mean 
that the clinical status could have deteriorated 
further in the meantime. 
The tables on gender and age show an equal 
sex distribution and most patients were 
between 70 and 80 years. The mean was 
75,43 years (SD: 6,50). 
The descriptive statistic representation of all 
clinical tests (Walk Test, Minimental Test and 
Pegboard Test) show an improvement for the 
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whole cohort 6 months after shunt 
implantation. The Walk Test and Minimental 
Test showed a clear improvement already 
after 3 days of Lumbar Drainage, whereas the 
Pegboard Test was found improved at 6 
months after VP Shunt implantation only. 
Then, however, it was the test with the highest 
number of excellent improvements (14 /21 
patients) compared to the other two tests. 
The Pegboard test is a principal test for the 
evaluation of the visuospatial and viso-
constructive perception, besides being a test 
of medium level cognitive demand [105]. It 
evaluates perception of a problem, translation 
in a motor program and hand skills / hand 
coordination required for complex visuomotor 
task [4]. The test results of a lower initial 
improvement rate, however the highest 
number of excellent improvements after 6 
months indicates, that complex systems seem 
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to react slower to changes after drainage than 
simpler tasks like walking. Furthermore it 
indicates that a visuospatial test, which is 
executed with the hands and thus is 
independent of other associated degenerative 
processes like, for example, those of spine 
and hip / knee joints, might be more robust 
and independent and thus more reliable for the 
evaluation after shunting than walking tests. 
The Kiefer Score, which is a mostly descriptive 
score, did only show an improvement 
tendency, which was not statistically significant 
and was thus inferior to identify improvement 
after shunting compared to test with objective 
data like for example the pegboard test.  
Another reason for this difference is the 
possible higher inter-observer variability of a 
clinical score with assessment / interview 
character like the Kiefer score compared to an 
objective measurement. In this study the 
  168 
scoring was often performed by different 
doctors, which introduced a factor of greater 
variability leading to a lower repeatability as 
compared to the pegboard or walking test 
which have a clear definition how to be 
performed and where variables can be 
measured in time and steps. 
 
Monitoring parameters: 
The patients included in this work showed in 
addition to clinical improvement after three 
days of lumbar drainage also ICP derived 
values thought to be predictive of clinical 
improvement once CSF is shunted. Three 
indices of a decreased craniospinal 
compliance or reserve capacity like elevated 
RAP, elevated Elastance and reduced PVI 
were taken into account for patient selection. 
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The first hypothesis was, that patients 
responding clinically to 3 days lumbar drainage 
trial would show indices of lowered intracranial 
compliance. Mean ICP in this cohort of 
patients was normal 9,2 mmHg (SD: 4,80). 
The ICP amplitude (AMP) (calculated as first 
harmonic after Fourier transformation) would 
be expected to be in a range of ≤ 1 mmHg at a 
normal intracranial compliance. However, in 
keeping with the hypothesis of low compliance, 
AMP mean was determined to be double that 
value 2,1 mmHg (SD:0, 68). In all 21 patients 
the AMP values were > 1 mmHg (see Table 
26). 
The RAP Index is the correlation coefficient 
between change of ICP and change of AMP. It 
is considered a measure of the intracranial 
reserve capacity [21]. In the physiological 
situation of a sufficiently large compliance and 
reserve capacity, with a flat pressure / volume 
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curve, changes in intracranial pressure will not 
be closely related to changes in ICP pulse 
amplitude, since there is a buffering capacity. 
Thus, the correlation index between ICP and 
AMP is around 0 or negative.  
In a situation of lowered compliance without 
much reserve capacity, the slope of the 
pressure/volume curve is steep. Thus, 
changes in ICP will more likely result in 
changes of AMP in the same direction which 
makes the correlation index positive. A 
threshold of higher than 0.6 is considered to 
be an indicator of significantly decreased 
craniospinal compliance [21]. Figure 32 and 
Table 26 compares the mean RAP index 
values before and after 3 days lumbar 
drainage. The mean RAP value during the 
initial overnight monitoring (deep sleep phase) 
was 0.71, and 19/21 patients were > 0.6, 
indicating a low compliance situation. This is in 
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keeping with the proposed situation in shunt 
responsive NPH patients according to the 
reasoning of the hydrodynamic theory, that a 
lowered intracranial compliance is present.  
In keeping with a low compliance situation 
indicated in the majority of patients during 
overnight monitoring by higher AMP and RAP, 
the values of Elastance and PVI, calculated 
from lumbar infusion study, could have been 
expected to be high (Elastance) or low (PVI) in 
those patients as well. However, this was only 
the case for a little more than 50% of patients 
and there was no correlation between PVI and 
Elastance on one hand and RAP/AMP results 
on the other hand. This indicates, that the data 
derived from ICP monitoring over a whole 
night and the results of a volume loading test 
applied to the spinal compartment within 30-60 
minutes are rather two sides of the same coin 
than measurements of the same component or 
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system of craniospinal compliance. During a 
volume load test the compliance parameters 
are determined by the speed (time) it takes to 
reach a new plateau. Here on one hand the 
amount of available intracranial and intraspinal 
blood, which can be displaced in response to 
an increase of CSF volume, plus on the other 
hand the ability of the lumbar dural sac to 
extend and accommodate additional volume 
without a larger rise in pressure are the two 
most likely determinants of Elastance and PVI. 
Thus there are two spinal contributors. For the 
RAP determination, however, only 
intracranially recorded ICP was taken. The 
ability to displace spinal blood and the 
influence of spinal dural compliance most likely 
has a lower influence on the correlation of 
changes in ICP and changes in AMP. 
Therefore the lack of correlation - RAP/AMP 
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on one hand and Elastance and PVI on the 
other hand - can be explained.  
In summary, the first hypothesis that patients 
which respond clinically to 3 three day lumbar 
drainage trial also show indices of decreased 
craniospinal compliance was thus proven 
valid. 
The second hypothesis was, that shunting 
primarily leads to an increase in intracranial 
compliance and restoration of reserve capacity 
by removing CSF. In the descriptive statistics 
we can see that apart from lowering ICP from 
the mid normal range to the lower normal 
range, the values of AMP, RAP and SLOW 
were significantly changed at the end of the 
lumbar drainage trial in the sense of a better – 
higher compliance. 
The change in ICP from a mean of 9.2 mmHg 
(SD: 4,8) to a mean of 4.0 mmHg (SD: 3,9) 
was rather moderate despite the fact that a 
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high volume drainage of several hundred ml of 
ICP was achieved during those three days.  
After lumbar drainage the RAP fell from a 
mean of 0.71 (SD: 0,14) to a mean of 0.45 
(SD: 0,2). This reflects the fact, that the 
removal of CSF by lumbar drainage did not 
only decrease the ICP but improved 
significantly the intracranial compliance 
situation. Most likely, the removal of CSF 
resulted in an increase of the intracranial blood 
volume within the venous capacitance vessels, 
which in turn increased the compliance. 
Therefore, one conclusion from the lumbar 
drainage trial is, that a shunt at least as much 
improves the intracranial compliance situation 
as it decreases the ICP, Most likely the first 
effect is the more important one, since the 
patients have a normal intracranial pressure 
anyways.  
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AMP did as well decrease after drainage in 
keeping with the theory of an increase in 
compliance from a mean of 2,1 mmHg (SD: 
0,68) to a mean of 1,3 mmHg (SD:0, 40). 
Interestingly, the mean value was still above 1 
mmHg, which is considered the threshold for a 
decreased intracranial compliance, however, 
now 6/21 patients had a mean AMP < 1 mmHg 
compared to 0/21 before drainage. In all other 
patients AMP decreased as well. 
In summary, the second hypothesis seems to 
be valid according to the results after lumbar 
drainage in this patient cohort.  
For the description of the clinical effects after 6 
months of shunt therapy we had two options at 
hand. First, there were the clinical tests 
performed initially and after 6 months and 
second all patients were scored with the Kiefer 
Score, which is a mixtures of description and 
measurements.  
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Regarding the clinical tests (Walking test, 
Pegboard test and Minimental test) an 
Improvement Index for assessment of change 
after 6 months of shunt therapy was calculated 
according to the equation: [(Test-Initial Value – 
Test-Value 6 Mo. after VP-Shunt / Test-Initial 
Value) x 10]. An improvement >15% was 
considered as Excellent, between 10-15% as 
Good, between 5-10% as Fair and <5% as 
Poor. This last value includes also all cases of 
clinical deterioration, which will be shown for 
each patient in the graphics.  
It should be noticed that the results for the 
three different tests, which measure three 
different aspects that can be affected by the 
disease, were different as could be expected.  
The test with the greatest number of patients 
that show an improvement index >15% was 
the Pegboard Test with a total of 14 of 21 
patients, taking one patients with an 
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improvement of >10%, there were 15 of 21 
patients with a sustained improvement at 6 
months.  
Regarding the Walk-Test half of the patients 
(12 of 21) showed an improvement index 
>10%, with 7 having excellent results > 15%.  
The test with the greatest number of patients 
without improvement (index <5%) was the 
Minimental test with a total of 11 of 21 
patients. Further 2 patients had only fair (index 
<10%) improvement, thus more than 60% of 
patients did not improve after shunting 
regarding their Minimental test results.  
It is because the iNPH represents a subcortical 
dementia and not a primary functional cortical 
disorder [24]. This test provides basically a fast 
and global measure of the cognitive 
alteration´s severity and allows to quantify the 
patient´s degree of cortical dementia [34], [4]. 
For this reason and in accordance with these 
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results, the Minimental test is no a good 
predictor of cognitive response in shunted 
patients. 
The NPH recovery rate was calculated 
according to the equation: [(Kiefer Initial Value 
– Kiefer Value 6 Mo. after VP-Shunt / Kiefer 
Initial Value) x 10]. An improvement ≥7 is 
considered as Excellent, ≥5 as Good, ≥3 as 
Fair, ≥ 2 as Transient and <2 as Poor. The 
long term response after shunt implantation 
shows that 12 patients were Poor (57%), 4 
were Fair (19%), and 5 were Good (24%) in 
relation to the initial test. There was no patient 
with a score ≥7, i. e., with an excellent long 
term response. The outcome 6 months after 
shunt as assessed with the Kiefer Scale based 
NPH recovery scale was thus worse compared 
to the scalable outcome measures. As already 
discussed above, the Kiefer Scale did not 
show such significant improvements, probably 
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due to a high variability in assessment of 
different doctors at different time points and in 
consequence the NPH recovery scale showed 
a much lower rate of improvement. 
Consequently, the correlation between NPH 
Recovery Rate in relation to the differences of 
Intracranial Monitoring results (ICM) after 
lumbar drainage (ICP, Slow, AMP, RAP) and 
after lumbar infusion study (E, PVI, Rout) was 
not significant (p>0,05) and the (H1) was 
rejected.  
The lineal correlation analysis of intracranial 
monitoring and lumbar infusion test variables 
in relation to the improvement in NPH recovery 
rate showed no or only a weak correlation. 
This can be explained by the fact that the 
sample was small and that the clinical results 
showed a great variability, which represents a 
disadvantage from a statistical analysis point 
of view. 
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The Comorbidity Index (CMI) shows in the 
descriptive statistics a non gausserian 
distribution of the sample with 17 patients 
within the range of 1 – 3 points and 4 Patients 
within 4 – 7 points. The statistical correlation 
between Comorbidity Index (CMI) on one hand 
and, NPH Recovery Rate and the 
Improvement Indeces (Walk Test, Pegboard 
Test and Minimental Test) on the other hand 
showed that there was no correlation between 
CMI and NPH Recovery Rate and CMI and 
Walk Test. However, the correlation between 
CMI and Pegboard Test (p: 0,043) and 
Minimental Test (p: 0,009) was significant 
(p≤0,05). The Minimental Test and Pegboard 
Test evaluate the cognitive and visual-spatial 
capabilities of the patient. These tests are 
objective and less influenced by external 
factors like orthopedic disorders, which could 
explain the fact, that here a correlation was 
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seen but none existed to the walking test. 
Recent studies state that the CMI plays a 
predictive role with regard to iNPH patients’ 
postoperative evolution. It is expected that the 
lower the preoperative CMI score is, the better 
the prognosis for a postoperative improvement 
[68]. In this sense, if the CMI score is 6 or 
greater, a clinical postoperative improvement 
cannot be expected [68]. According to this, in 
our study only 2 of 21 patients had a CMI 
greater than 6. Although both patients had a 
clinical improvement after the lumbar drainage 
they did not showed any clinical improvement, 
when they were controlled 6 months after the 
VP Shunt implantation. Only one patient of the 
sample that had more than 4 points at the CMI 
scale showed a clinical improvement 6 months  
postoperatively. Concur with Lemcke and 
Meier [68], these findings underscore the fact 
that comorbidity is a statistically significant and 
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a serious negative predictor in the treatment of 
these patients. The role of CMI as a predictive 
parameter is related to a variety of pathologies 
(including vascular risk factors, 
cerebrovascular disease, peripheral vascular 
occlusions and others illnesses like 
Parkinson’s disease), their severity, and the 
medical and psychosocial treatment and also 
the rehabilitation that the patient receives. 
There is no doubt that the factors included in 
the CMI can induce directly or indirectly a 
rising cerebrovascular resistance and 
decrease of vascular compliance (loss of 
Windkessel) which will further enhance the 
hyperpulsatility already promoted by the 
decrease of intracranial compliance. 
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6 Conclusions 
The purpose of this work was to demonstrate 
in patients with suspected iNPH, which are 
considered as probably shunt responders, that 
indices taken from ICP monitoring and lumbar 
infusion study, will be consistent with a 
coexisting lowered intracranial or craniospinal 
compliance. The current concept of iNPH 
involves the idea, apart from being the only 
variant of dementia disorders possibly 
treatable by neurosurgical intervention [69], 
that its pathophysiological process can be 
explain through a decrease of intracranial 
compliance (resulting in a complex dysfunction 
of cerebral blood flow in parallel to a change in 
CSF dynamics). The second hypothesis was 
that a three day lumbar drainage protocol 
would improve intracranial compliance, since 
our hypothesis was that this is the main effect 
of a shunt that leads to a clinical improvement. 
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Both of these hypothesis could be proven by 
the investigation.  
However, we furthermore demonstrated that 
there was only a weak direct correlation 
between the intracranial monitoring and 
lumbar infusion test variables to the 
improvement in clinical tests. Especially the 
Kiefer Score and the dependent "NPH 
recovery rate", which are both subject to a 
great deal of interpretation of the interviewer, 
were not well correlated and did not show a 
comparable improvement as did the more 
objective outcome measures "walk test" and 
"pegboard test". 
The weak correlation could have also been 
negatively influenced by the fact that the 
sample was small and that the clinical results 
were greatly variable, which represents a 
disadvantage from a statistical analysis point 
of view.  
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We could clearly demonstrate, that patients 
responding to three days lumbar drainage trial 
showed indices of lowered intracranial 
compliance and that shunting these patients 
primarily leads to an increase in intracranial 
compliance and restoration for reserve 
capacity by removing CSF. Therefore we 
suggest, that the combination of computerized 
analysis of intracranial pressure and 
cerebrospinal fluid dynamics with the lumbar 
infusion test and three days lumbar drainage 
represent, although an extensive procedure, 
the most accurate way to diagnose shunt 
responsive idiopathic normal pressure 
hydrocephalus. Future research needs to be 
directed towards a simplification of the 
diagnostic procedures without loosing the 
diagnostic accuracy. This dissertation, besides 
trying to demonstrate the importance and 
usefulness of the invasive techniques and 
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diagnosis protocols in dealing with iNPH, 
furthermore has a large introductory section on 
the theoretical foundations of the current 
theories regarding a low compliance situation 
with intracranial hyperpulsatility. Despite its 
length and extend, this section demonstrates 
the extensive work undertaken in the attempt 
to understand and elucidate as much as 
possible the theoretical background of a 
complex pathophysiology. 
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7 Zusammenfassung und Ausblick 
Ziel dieser Arbeit war, bei Patienten mit 
idiopathischem Normaldruckhydrocephalus 
(iNPH), die als potentielle „Responder“ einer 
Therapie mit einem ventrickulo-peritonealen 
Shunt angesehen werden, mit Hilfe invasiver 
Methoden (computerisierte nächtliche 
Hirndruckanalyse und lumbale Infusionsstudie) 
nachzuweisen, dass eine erniedrigte 
intrakranielle Compliance vorliegt. Die 
momentan besterklärende 
pathophysiologische Hypothese zum iNPH 
geht davon aus, dass der Erkrankung eine 
über die erniedrigte Compliance bedingte 
Pulsatilitätsstörung von Blut und Liquor mit 
assoziierter Beeinträchtigung des zerebralen 
Blutflusses zugrunde liegt.  
 
Die 2. Hypothese der Arbeit war, daß eine 
dreitägige Lumbaldrainage, die zu einer 
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klinischen Verbesserung des Patienten führt, 
mit einer Zunahme der intrakraniellen 
Compliance und Verbesserung der 
Reservekapazität einhergeht. Dies würde 
unsere Auffassung stärken, dass der 
wesentliche Effekt der Shunttherapie über die 
Verbesserung der Compliance vermittelt wird.  
Beide Hypothesen konnten in der Arbeit 
bestätigt werden.  
 
In Bezug auf die Korrelation des klinischen 
Scores (Kiefer Scale und der darauf 
basierenden NPH Recovery Rate) fanden wir 
keine überzeugende Korrelation zum Ausmaß 
der Besserung und dem Ausmaß der 
Veränderung der compliance assoziierten 
Messwerte. Neben der kleinen 
Patientenanzahl ist dies wahrscheinlich darin 
begründet, dass der Kiefer Scale unscharfe 
und subjektive Einschätzungen von Patient 
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und Arzt beinhaltet. Eine deutlich bessere 
Korrelation fand sich zu objektiven 
Messverfahren wie Gangtest und Pegboard 
Test. 
 
Zusammenfassend konnte die Arbeit 
nachweisen, dass bei Patienten mit 
vermutetem iNPH eine erniedrigte cranio-
spinale Compliance assoziiert ist mit einem 
guten Ansprechen auf eine dreitägige 
Liquorprobedrainage und nachfolgend einer 
Shunttherapie , und, dass die dabei bewirkte 
Entfernung vom Nervenwasser zu einer 
Erhöhung der  intrakraniellen Compliance 
führt. Daraus folgt, dass die Kombination einer 
computerisierten Analyse des intrakraniellen 
Druckes und der cerebrospinal Liquordynamik 
(lumbale Infusionsstudie) eine aufwändige 
aber präzise pathophysiologisch orientierte 
Methode der Diagnose von jenen 
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Normaldruckhydrocephalus Patienten ist, bei 
denen eine klinischen Verbesserung nach 
Shunt Implatantion zu erwarten ist. Zukünftige 
Arbeiten sollten zum Ziel haben, eine 
Simplifizierung der Diagnostik bei 
gleichbleibenden Aussagekraft, idealerweise 
unter Verwendung weniger invasiver 
Verfahren, zu erreichen. 
 
 
 
 
 
 
 
 
 
 
Jordana Sosa - Prof. Dr. med. M. Schuhmann 
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